




















are	 often	 associated	 with	 viral	 infections,	 most	 commonly	 rhinovirus.	 Rhinoviral	
infection	 of	 airway	 epithelial	 cells	 initiates	 several	 signalling	 pathways,	 including	 the	
MAPK	pathways,	leading	to	the	production	of	inflammatory	cytokines.	It	is	of	extreme	
importance	that	these	pathways	are	regulated	to	prevent	excessive	inflammation.	Dual	
specificity	 phosphatases	 (DUSPs)	 are	 known	 to	 negatively	 regulate	 the	 MAPKs	 in	
bacterial	infection	of	macrophages.	I	hypothesised	that	DUSPs	would	play	an	important	
role	in	regulating	the	inflammatory	response	to	rhinoviral	infection.		
The	 response	 of	 primary	 bronchial	 epithelial	 cells	 (PBECs)	 to	 rhinoviral	 infection,	
stimulation	 with	 the	 synthetic	 double-stranded	 RNA	 poly(I:C),	 or	 the	 inflammatory	
cytokine	IL-1b,	was	characterised.	Stimulation	or	infection	of	PBECs	led	to	production	of	









consistently	 produced	 higher	 CXCL8	 in	 response	 to	 IL-1b	 stimulation,	 an	 important	
molecule	 in	 communication	 between	 macrophages	 and	 epithelial	 cells.	 Rhinovirus	
replicated	well	 in	monocytes,	and	transfer	of	supernatants	from	monocytes	to	PBECs	
induced	CXCL8	production,	which	was	increased	when	DUSP10	was	knocked	down.		
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of	 the	 bronchi	 (Reviewed	 in:	 Barnes	 et	 al.,	 2003).	 Each	 of	 these	 diseases	 leads	 to	
decreased	 air	 flow	with	 common	 symptoms	of	 breathlessness	 and	persistent	 cough.	




The	 major	 cause	 of	 hospitalisations	 and	 mortality	 in	 asthma	 and	 COPD	 are	 acute	
exacerbations	where	inflammation	causes	obstruction	of	the	small	airways	(Gern,	2010).	




is	 respiratory	 viral	 infections.	 Several	 studies	 have	 examined	 the	 prevalence	 of	
respiratory	 viruses	 in	 acute	 exacerbations	 of	 asthma	 and	 COPD.	 In	 asthma,	 the	




2007,	 Kling	 et	 al.,	 2005,	Miller	 et	 al.,	 2016,	Wark	 et	 al.,	 2002).	 In	 COPD,	 respiratory	
viruses	were	found	in	37-56%	of	acute	exacerbations,	64%	of	which	were	rhinoviruses	
(McManus	 et	 al.,	 2008,	 Rohde	 et	 al.,	 2003).	 In	 COPD,	 these	 exacerbations	 are	more	
severe	and	frequent	than	non-virally	 induced	exacerbations	(Seemungal	et	al.,	2001).	
Asthma	 morbidity	 correlates	 with	 the	 isolation	 of	 human	 rhinoviruses	 from	 the	
community,	with	peaks	in	September	and	spring	(Johnston	et	al.,	2006).		











thus	 mucus	 production,	 along	 with	 an	 increase	 in	 smooth	 muscle	 and	 airway	
remodelling	with	deposition	of	collagen	and	fibronectin	under	the	epithelial	basement	
membrane	 (Lambrecht	 and	 Hammad,	 2012).	 Rhinovirus	 itself	 can	 also	 damage	 the	




from	asthmatics	 secrete	 reduced	amounts	of	 type	 I	 and	 type	 III	 interferons	 (IFNs)	 in	
response	to	infection	with	two	serotypes	of	rhinovirus,	RV16	and	RV1B,	in	comparison	
to	cells	from	healthy	donors	(Contoli	et	al.,	2006,	Edwards	et	al.,	2013,	Wark	et	al.,	2005).	
This	deficiency	was	also	associated	with	an	 increase	 in	viral	 replication,	although	the	








well	 as	 IFN	 deficiency,	many	 asthmatics	 have	 a	 skewed	 adaptive	 immune	 response,	
towards	the	T	helper	2	(Th2)	axis,	leading	to	allergic	eosinophilic	inflammation	(Message	
et	al.,	2008,	Woodruff	et	al.,	2009).	This	eosinophilic	response	has	been	correlated	to	











grouped	 into	 RV-A,	 RV-B	 and	 RV-C	 based	 on	 phylogenetic	 analysis.	 Group	 C	 was	













at	37oC	 (Papadopoulos	et	al.,	1999)	and	 in	experimental	 infection	of	human	subjects	
rhinovirus	 has	 been	 recovered	 from	 the	 lower	 respiratory	 tract	 (Gern	 et	 al.,	 1997).	
Rhinovirus	binds	to	receptors	on	the	surface	of	epithelial	cells,	ICAM-1,	LDLR	or	CDHR3,	
triggering	 receptor	 mediated	 internalisation.	 This	 internalisation	 can	 be	 via	 clathrin	
dependent	 or	 independent	 endocytosis,	 or	 micropinocytosis,	 depending	 on	 the	





















polyprotein.	 The	 polyprotein	 is	 then	 cleaved	 into	 viral	 proteins.	 The	 virus	 forms	
replication	complexes	where	the	RNA	is	replicated	and	the	virus	particles	assemble.	The	





The	 respiratory	 tract	 needs	 to	 be	 protected	 from	 the	 constant	 influx	 of	 inhaled	
pathogens.	A	 layer	of	sticky	mucus	covers	the	epithelium,	trapping	pathogens	before	







macrophages	 are	 capable	 of	 phagocytosing	 and	 killing	 pathogens,	 and	 secreting	
inflammatory	mediators.	However,	the	epithelial	cells	lining	the	airways	are	often	the	
first	line	of	defence.	These	cells	express	pattern	recognition	receptors	(PRRs),	both	on	
the	 plasma	membrane	 and	 within	 the	 cell	 in	 the	 cytoplasm	 and	 endosomes,	 which	
recognise	 pathogen-associated	 molecular	 patterns	 (PAMPs)	 and	 damage-associated	
molecular	patterns	(DAMPs)	(Section	1.3.1)	(Sha	et	al.,	2004).	This	gives	these	cells	the	
ability	to	monitor	both	the	external	and	internal	environment.	Binding	of	ligands	to	PRRs	









Rhinovirus	 particles	 infect	 epithelial	 cells	 through	 binding	 to	 either	 ICAM-1,	 LDLR	 or	
CHDR-3.	This	induces	epithelial	cells	to	secrete	cytokines	including	chemokines	and	IFN.	







1.1).	 When	 activated	 by	 a	 ligand,	 the	 TLRs	 oligomerise	 and	 form	 multi-subunit	
complexes	 which	 initiate	 signalling	 cascades	 leading	 to	 the	 activation	 and	 nuclear	
translocation	of	a	variety	of	 transcription	 factors,	 including	NF-κB,	AP-1,	CREB,	c/EBP	















RIG-I	 like	 receptors	 (RLRs),	 another	 virus-specific	 family	 of	 PRRs,	 are	 present	 in	 the	
cytosol	where	they	can	detect	the	double	stranded	RNA	(dsRNA)	produced	by	actively	
replicating	viruses	and	5’-triphosphorylated	single	stranded	RNA	(ssRNA)	 (Kato	et	al.,	
2008,	Hornung	et	 al.,	 2006).	 This	 family	 consists	 of	 three	proteins:	 RIG-I,	MDA5	and	
LGP2.	 Like	 TLRs	 3,	 7	 and	 8,	 RIG-I	 and	 MDA5	 bind	 viral	 RNA	 and	 initiate	 signalling	
pathways,	leading	to	the	activation	of	the	transcription	factors	NF-κB	and	IRF3	(Section	


























silence	 different	 PRRs	 in	 rhinovirus	 infection	 and	 determined	 the	 effect	 on	 IFN	 and	
cytokine	production	(Wang	et	al.,	2009,	Slater	et	al.,	2010).	Both	groups	found	that	TLR3	
and	MDA5	play	important	roles	in	the	detection	of	rhinovirus	but	they	disagreed	on	the	





human	 bronchial	 epithelial	 cells.	 In	 addition,	 the	 study	 by	 Slater	 et	 al.	 found	 that	






They	 suggest	 that	TLR2,	TLR7	and	TLR8	play	a	major	 role	 in	 rhinoviral	 recognition	 in	


































IKKα	 and	 IKKβ	 by	 phosphorylation	 (Wang	 et	 al.,	 2001).	 IKKβ	 subsequently	
phosphorylates	p105	and	 IκBα,	 targeting	 them	for	polyubiquitination	by	SCFβ-TrCP	and	
proteosomal	 degradation	 (Yaron	 et	 al.,	 1998).	 p105	 is	 degraded	 leaving	 a	 smaller	















































There	 are	 four	 proteins	 in	 the	p38	 family:	 p38α,	 p38β,	 p38γ	 and	p38δ.	Not	much	 is	




from	 lipopolysaccharide	 (LPS)	 induced	endotoxic	shock	and	decreases	 the	amount	of	
inflammatory	cytokines	produced	by	peritoneal	macrophages	from	these	mice	in	vitro,	
including	TNFα,	IL-12	and	IL-18	(Kang	et	al.,	2008).	p38α	also	has	a	role	in	inducing	anti-
















ERK1	 and	 2	 also	 have	 roles	 in	 inducing	 pro-inflammatory	 cytokines.	 ERK1	 and	 2	 are	
activated	by	phosphorylation	by	the	MKK	MEK1,	which	is	activated	by	Tpl2	(Beinke	et	
al.,	 2004).	 Peritoneal	 macrophages	 isolated	 from	 Tpl2	 knockout	 mice	 produce	






Figure	 1.3	 Innate	 immune	 signalling	 pathways	 initiated	 by	 viral	 infection	 of	 an	
epithelial	cell.	
TLR3	 binds	 dsRNA	 within	 the	 endosome.	 TLR3	 recruits	 TRIF	 which	 mediates	 two	
pathways.	TRIF	interacts	with	TRAF3,	TBK1	and	IKKi.	TBK1	and	IKKi	phosphorylate	the	







from	 its	 inhibition,	 which	 phosphorylates	 MEK1,	 a	 MKK.	 Other	 MKKs,	 MKK3/6	 and	
MKK4/7,	 are	 phosphorylated	 by	 TAK1.	 The	 MKKs	 phosphorylate	 the	 MAPKs	 which	
translocate	 to	 the	 nucleus	 and	 phosphorylate	 and	 activate	 a	 variety	 of	 transcription	













TLR3	 activation	 on	 the	 MAPKs	 using	 a	 synthetic	 double	 stranded	 RNA	 molecule:	


























activate	 this	 pathway,	 although	 they	 may	 activate	 similar	 kinases	 through	 different	
means.	For	example,	Newcomb	et	al	demonstrated	that	 infection	of	a	human	airway	
epithelial	 cell	 line	with	 RV1B,	 a	minor	 group	 rhinovirus,	 induced	 activation	 of	 Akt,	 a	









al.,	 2000).	 They	 found	 that	 infection	with	 RV39	 caused	 a	 time	 and	 dose	 dependant	
increase	in	p38	phosphorylation.	Treatment	with	either	inhibitor	prior	to	infection	led	













host	 cell	 endocytosis	 machinery,	 mainly	 the	 protein	 Rab11,	 to	 traffic	 cholesterol	 to	
replication	organelles	(Ilnytska	et	al.,	2013).	p38	has	been	shown	to	have	a	role	in	the	
endocytosis	 pathway:	 it	 phosphorylates	 and	 activates	 guanyl-nucleotide	 dissociation	



































IFNs	 are	 IFN-a	 and	 IFN-b.	 IFN-a	 and	 b	 have	 similar	 structures	 and	 bind	 the	 same	
receptor:	a	complex	of	two	subunits	 IFN-a,	b	and	w	 receptor	(IFNAR)-1	and	IFNAR-2.	
Infection	of	primary	bronchial	epithelial	cells	with	RV1B	or	RV16	was	shown	to	induce	














III	 (Zhou	et	al.,	2007).	 IFN-l	mRNA	production	has	been	shown	to	be	upregulated	 in	







MyD88	 and	 induces	 activation	 of	 the	 TRAF6	 signalling	 pathway	 (Section	 1.3.2)	
(Medzhitov	et	al.,	1998).	IL-1β	has	been	shown	to	have	an	important	role	in	inducing	
cytokine	 release	 in	 rhinoviral	 infection,	 as	 treatment	 of	 BEAS-2B	 cells	 with	 the	 IL-1	











1998).	 Indeed,	 higher	 levels	 of	 CXCL8	 have	 been	 found	 to	 correlate	 with	 symptom	
severity	 in	 rhinoviral	 infection	 (Turner	 et	 al.,	 1998,	 Ordonez	 et	 al.,	 2000)	 and	 nasal	






In	 order	 to	 stop	 overproduction	 of	 inflammatory	 markers	 and	 immune	 mediated	
























DUSP1	 MKP-1	 39.30	 p38	and	JNK	 Nuclear	 (Zhao	et	al.,	2005)	
DUSP2	 PAC-1	 34.40	 JNK	 Nuclear	 (Jeffrey	et	al.,	
2006)	
DUSP4	 MKP-2	 42.95	 ERK	 Nuclear	 (Cornell	et	al.,	
2010)	








Figure	 1.5	 Regulation	 of	 the	MAPK	 pathways	 by	 DUSP	 proteins	 in	 innate	 immune	
signalling.		
The	MAPKs	 are	 activated	 by	 a	 phosphorylation	 cascade:	 the	MKKKs	 TAK1	 and	 Tpl2	
phosphorylate	the	MKKs	MKK4/7,	MKK3/6	and	MEK1	which	phosphorylate	the	MAPKs	
which	 then	 translocate	 to	 the	 nucleus	 and	 activate	 transcription	 factors	 and	 other	
kinases.	Two	kinases	activated	by	p38	and	ERK1/2	are	MSK1	and	MSK2.	These	activate	
transcription	 factors	 NF-κB	 and	 CREB/ATF.	 CREB/ATF	 then	 induces	 transcription	 of	
DUSPs	1,	2	and	4.	The	DUSP	proteins	inhibit	these	pathways	by	dephosphorylating	the	
MAPKs:	DUSP1	and	DUSP10	dephosphorylate	p38	and	JNK1/2,	DUSP2	dephosphorylates	





The	 most	 well-studied	 of	 the	 DUSP	 proteins	 is	 the	 nuclear	 protein	 DUSP1.	 DUSP1	
preferentially	dephosphorylates	p38	and	JNK,	but	is	capable	of	dephosphorylating	ERK	
(Chi	et	al.,	2006,	Franklin	and	Kraft,	1997).	Studies	from	knockout	mice	have	shown	the	




and	 CXCL2,	when	 challenged	with	 LPS,	 or	 live	 bacteria,	 in	 vitro	 (Frazier	 et	 al.,	 2009,	
Hammer	et	al.,	 2006,	Talwar	et	al.,	 2017).	 In	each	 study	 this	excessive	 inflammatory	
response	 was	 associated	 with	 increased	 and	 prolonged	 activation	 of	 p38	 and	 JNK	








et	 al.,	 2017).	 This	 indicates	 that	 regulation	 of	 p38	 and	 JNK	 signalling	 in	 response	 to	
bacteria	by	DUSP1	is	extremely	important	in	minimising	the	amount	of	damage	caused	
by	inflammation.		
DUSP1	may	also	be	able	 to	positively	 regulate	expression	of	 some	genes.	During	 the	













compared	 to	wild	 type,	 and	 this	was	 associated	with	 a	 decrease	 in	 translocation	 of	
ARE/Poly(U)	 binding	 degradation	 factor	 1	 (AUF1),	 a	 protein	 which	 binds	mRNA	 and	
recruits	degradation	machinery,	from	the	nucleus	to	the	cytoplasm	(Yu	et	al.,	2011).	This	
may	 be	 an	 additional	 result	 of	 p38	 dephosphorylation,	 as	 it	 has	 been	 found	 that	
treatment	 with	 another	 imidazole	 p38	 inhibitor,	 SK&F	 86002,	 promotes	 AUF1-
dependant	mRNA	decay	in	primary	human	monocytes	(Sirenko	et	al.,	1997).	DUSP1	also	
activates	tristetraprolin	 (TTP),	another	mRNA	destabilising	factor,	which	binds	to	and	
induces	the	decay	of	mRNA	for	several	 inflammatory	cytokines.	TTP	 is	 inactivated	by	









using	 siRNA	 significantly	 increased	 both	 induction	 and	 secretion	 of	 two	 pro-
inflammatory	cytokines,	CXCL8	and	IL-6,	in	response	to	poly(I:C)	(Golebski	et	al.,	2015).	
DUSP1	is	also	induced	by	infection	with	viruses:	Ebola	infection	of	the	human	hepatoma	











(HCV).	 This	 was	 found	 to	 be	 due	 to	 increased	 STAT1	 activation	 and	 induction	 of	
interferon	 stimulated	 genes,	 suggesting	DUSP1	dephosphorylates	 STAT1	 (Choi	 et	 al.,	
2015).	
1.5.3 Regulation	of	DUSP1	
DUSP1	 is	 transcriptionally	 induced	 by	 a	 negative	 feedback	mechanism:	 p38	 and	 ERK	
activate	the	kinases	MSK1	or	MSK2	which	phosphorylate	the	transcription	factors	CREB	
and	 ATF1,	 which	 then	 bind	 to	 the	 promoter	 of	 the	 gene	 for	 DUSP1	 and	 initiate	 its	





mice	 for	 either	unable	 to	upregulate	DUSP1	 (Chi	 et	 al.,	 2006).	However,	 it	 has	been	
suggested	that	pretreatment	of	macrophages	with	IFN-γ	can	decrease	the	induction	of	
DUSP1	by	LPS	(Zhao	et	al.,	2005).	DUSP1	is	also	regulated	by	the	stability	of	its	mRNA,	
inhibition	 of	 the	 pro-inflammatory	 cytokine	 macrophage	 migration	 inhibitory	 factor	
(MIF)	has	been	found	to	increase	DUSP1	mRNA	stability	in	the	RAW	264.7	macrophage	
cell	 line	 (Gao	 et	 al.,	 2017).	 DUSP1	 protein	 stability	 can	 also	 be	 regulated:	








































produce	 higher	 levels	 of	 inflammatory	 cytokines,	 including	 IL-6	 and	 TNFα,	 to	









et	 al.,	 2016,	 James	 et	 al.,	 2015).	 When	 DUSP10	 knockout	 mice	 were	 infected	 with	











(Grumont	 et	 al.,	 1996,	 Pise-Masison	 et	 al.,	 2002).	 When	 knocked	 out	 in	 mice	 the	
inflammatory	 signalling	 in	 response	 to	 LPS	 is	 decreased,	 suggesting,	 in	 contrast	with	
DUSP1	and	DUSP10,	a	positive	rather	 than	negative	regulatory	role	 for	DUSP2	 in	 the	
immune	response.	In	mast	cells	and	macrophages	taken	from	these	mice,	the	decreased	
release	of	 inflammatory	markers	was	associated	with	an	 increase	 in	phosphorylation	
and	activity	of	JNK,	but	a	decrease	in	p38	and	ERK,	which	the	authors	proposed	was	due	
to	cross-talk	between	 the	 JNK	and	ERK	pathways	 (Jeffrey	et	al.,	2006).	This	model	 is	
supported	by	an	earlier	study	showing	that	JNK	activity	blocked	the	phosphorylation	of	
ERK	 by	 MEK1,	 and	 that	 this	 inhibition	 was	 dependant	 on	 c-Jun	 mediated	 gene	
transcription.	 This	 implies	 JNK	 activation	 leads	 to	 induction	 of	 an	 unknown	 protein,	
through	activation	of	AP-1,	which	blocks	ERK	phosphorylation	(Shen	et	al.,	2003).	In	this	
model	DUSP2	would	inactivate	JNK,	stopping	activation	of	AP-1,	the	unknown	protein	
which	 blocks	 ERK	 phosphorylation	 is	 therefore	 not	 expressed,	 and	 thus	 the	 pro-
inflammatory	activity	of	ERK	is	increased.		





DUSP1	 it	 can	 be	 phosphorylated	 by	 ERK	 at	 Ser386	 and	 Ser391,	 which	 stabilises	 the	




these	 mice	 showed	 this	 decrease	 was	 associated	 with	 an	 increase	 in	 ERK	 activity,	
decreases	 in	 p38	 and	 JNK	 activity,	 and	 increased	 induction	 of	DUSP1	protein.	When	
DUSP1	was	knocked	down,	using	siRNA,	in	these	DUSP4	knock	out	BMDMs,	the	release	
of	 pro-inflammatory	 cytokines	 increased	 (Cornell	 et	 al.,	 2010).	 The	 authors	 suggest	
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could	 partially	 account	 for	 the	 excessive	 inflammatory	 response	 to	 respiratory	
infections.	A	study	 in	2008	 isolated	nasal	epithelial	cells	 from	healthy	 individuals	and	
patients	with	house	dust	mite	allergy,	a	common	allergy	associated	with	asthma.	They	
performed	 a	 microarray	 to	 determine	 any	 gene	 expression	 changes	 in	 response	 to	
stimulation	with	house	dust	mite.	In	non-allergic	controls,	DUSP1	mRNA	expression	was	
upregulated	 in	 response	 to	 house	 dust	mite	 challenge,	 however,	 in	 allergic	 patients	
DUSP1	expression	did	not	alter	(Vroling	et	al.,	2008).	DUSP10	may	also	have	differential	
expression	 in	 asthmatic	 patients.	 A	 transcriptional	 profile	 of	 Th2	 cells	 taken	 from	
asthmatic	and	healthy	subjects	showed	lower	baseline	mRNA	expression	of	DUSP10	in	
the	asthmatic	cells	than	the	healthy	cells	(Seumois	et	al.,	2016).		
Interestingly,	 a	 study	 in	 2012	 looking	 for	 genetic	 determinants	 for	 severe	 asthma	








Rosenberg	 and	 Kalhan,	 2017).	 Steroids	 act	 to	 limit	 inflammation	 by	 interacting	with	
glucocorticoid	receptors	(GRs)	in	the	cytosol,	this	causes	a	conformational	change	in	the	
GR	which	allows	 it	 to	 translocate	 to	 the	nucleus,	where	 it	 interacts	with	and	 inhibits	
transcription	factors,	such	as	AP-1	and	NF-κB	(Heck	et	al.,	1994,	Ray	and	Prefontaine,	
1994).	More	recent	evidence	suggests	that	glucocorticoids	mediate	many	of	their	anti-
inflammatory	 actions	 through	 DUSP1.	 Treatment	 of	 cells	 with	 the	 glucocorticoid	
dexamethasone	causes	an	 increase	 in	DUSP1	expression	 in	many	different	cell	 types,	
including:	primary	peripheral	blood	neutrophils;	primary	airway	smooth	muscle	cells;	
murine	BMDMs;	 the	epithelial	 cell	 lines	A549,	BEAS-2B,	 and	HeLa	 cells;	 the	RBL-2H3	
basophil	line	and	the	NIH-3T3	fibroblast	cell	line	(Kassel	et	al.,	2001,	Keranen	et	al.,	2017,	
King	et	al.,	2009,	Lasa	et	al.,	2002,	Prabhala	et	al.,	2016,	Rahman	et	al.,	2016,	Wang	et	




dexamethasone	 on	 inflammatory	 cytokine	 expression	 in	 response	 to	 LPS	 was	 also	
negated	in	the	DUSP1	knock	out	cells	(Abraham	et	al.,	2006).	Bone-marrow	derived	mast	
cells	 taken	 from	 DUSP1	 knock	 out	 mice	 had	 higher	 levels	 of	 MAPK	 activation	 in	
dexamethasone	 treated	 cells.	 However,	 the	 expression	 of	 inflammatory	 cytokines	 in	
response	to	IgE	crosslinking	did	not	differ	significantly	between	wild-type	and	knock	out	
cells	 (Maier	 et	 al.,	 2007).	 The	 authors	 suggest	 this	 may	 be	 due	 to	 compensatory	
mechanisms,	 a	 theory	 supported	 by	 the	 fact	 that	 dexamethasone	 treatment	 also	















affect	 the	 upregulation	 of	 DUSP1.	 However,	 treatment	 with	 Pam3CSK4	 did	 induce	
oxidative	 stress,	 and	 a	 proportion	 of	 the	 DUSP1	 present	 in	 these	 cells	was	 oxidised	
(Rahman	et	al.,	2016).	As	discussed	in	section	1.5.3,	oxidation	of	the	catalytic	cysteine	
residue	of	DUSP1	inactivates	its	phosphatase	activity.	This	suggests	that	the	resistance	
of	 exacerbations	 caused	 by	 infection	 to	 steroid	 treatment	may	 be	 in	 part	 due	 to	 a	






effects	 (Fernandes	 et	 al.,	 2014).	 Therefore,	 a	 more	 targeted	 therapy,	 aimed	 at	
upregulating	DUSP1,	may	be	preferable.			
1.7 Hypothesis	and	Aims	




studied.	 I	 hypothesised	 that	 DUSPs	 have	 important	 roles	 in	 regulating	 inflammatory	
cytokine	release	in	epithelial	cells	in	response	to	rhinoviral	infection.	If	this	hypothesis	




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Water	 1.9	 0.68	 	
30%	acrylamide	mix	 1.7	 0.17	 Geneflow	
1.5	M	Tris	(pH	8.8)	 1.3	 0	 BioRad	
1.0	M	Tris	(pH6.8)	 0	 0.13	 BioRad	
10%	SDS	 0.05	 0.01	 Panreac	
10%	ammonium	persulfate	 0.05	 0.01	 Fluka	
























All	 cells	were	 tested	monthly	 for	 the	 presence	 of	mycoplasma	by	 technicians	 in	 the	
department.	 The	 EZ-PCR	mycoplasma	 test	 kit	 (Geneflow)	was	 used	 according	 to	 the	
manufacturer’s	instructions.		
2.2.5 Peripheral-Blood	Mononuclear	Cell	Isolation		
Peripheral	 venous	 blood	 was	 obtained	 from	 healthy	 human	 volunteers	 with	 fully	
informed	 consent,	 in	 accordance	with	 a	 protocol	 approved	 by	 South	 Sheffield	 Local	
Research	Ethics	Committee.	
	46	
Peripheral-blood	 mononuclear	 cells	 (PBMCs)	 were	 isolated	 from	 blood	 by	 other	
members	of	the	department.	Freshly	drawn	blood	was	added	to	3.8%	tri-sodium	citrate	
(Martingdale	 Pharmaceuticals)	 and	 mixed	 gently	 before	 centrifuging	 at	 350	 g,	 20	
minutes,	 room	 temperature.	 The	 upper	 phase,	 containing	 platelet-rich-plasma,	 was	
transferred	to	a	fresh	50	ml	falcon	tube	and	centrifuged	at	800	g,	20	min,	20oC,	in	order	
to	 remove	platelets.	 The	 supernatant	was	 transferred	 to	a	 fresh	 tube	and	 the	pellet	




centrifuged	 at	 320	 g,	 6	 min,	 20oC.	 The	 supernatant	 was	 discarded	 and	 the	 pellet	
resuspended	in	2	ml	platelet-poor-plasma.	A	percoll	gradient	was	made,	containing	a	
lower	phase	of	51%	percoll	(GE	Healthcare)	and	49%	platelet-poor-plasma	and	an	upper	








a	24-well	 culture	plate	 (Costar).	 Cells	were	 incubated	at	37oC,	5%	CO2	 for	one	hour.	



















using	3	ml	MACS	buffer.	The	cell	 suspension	was	added	 to	 the	column	and	 the	 flow	

























































by	adding	500	µl	of	 virus	 to	a	 centrifugal	 filter	with	a	membrane	nominal	molecular	













Short	 interfering	RNA	 (siRNA)	was	used	 to	knock	down	DUSP10	mRNA	expression	 in	
PBECs.	PBECs	were	seeded	at	7x105	cells	per	plate	onto	12	well	culture	plates	(Costar)	






to	 each	well	 and	 plates	were	 incubated	 at	 37oC,	 5%	CO2,	 for	 4	 h	 before	media	was	
	50	






reached	 the	desired	confluency,	 indicated	 in	 figure	 legends.	The	above	protocol	was	
used	 for	 each	 of	 four	 different	 DUSP1	 siRNAs	 (Table	 2.7),	 varying	 the	 final	




Knock	 down	 in	 BEAS-2B	 cells	 was	 also	 attempted	 using	 Viromer	 Blue	 transfection	




































Cell-free	 supernatant	 was	 collected	 under	 sterile	 conditions	 (Section	 2.9.1)	 from	
monocyte	cultures	from	three	donors	infected	with	RV1B	or	RV16	for	24	or	48	h	(Section	
2.5.2)	and	stored	at	-80oC.	All	samples	were	thawed	and	all	three	donors	pooled	into	






















The	 aqueous	 phase	was	 transferred	 to	 a	 clean	 1.5	ml	 tube.	 500	µl	 isopropanol	was	
added,	and	samples	stood	at	room	temperature	for	10	minutes	before	centrifuging	at	
4oC	for	10	minutes	at	12000	g,	and	discarding	the	supernatant.	The	pellet	was	washed	


































(Section	 2.12.3)	was	 added	 to	 each	well	 of	 a	 384	well	 plate.	 Two	different	 qRT-PCR	















shaking,	 over-night.	 The	 culture	was	 then	 centrifuged	 8000	g,	 10	min,	 4oC,	 and	 the	
supernatant	discarded.	The	pellet	was	resuspended	in	250	µl	resuspension	solution	and	








step	 was	 repeated	 in	 order	 to	 collect	 the	 maximum	 amount	 of	 plasmid	 DNA.	 The	




b	 mRNA,	 and	 to	 determine	 viral	 replication	 using	 primers	 specific	 to	 part	 of	 the	
rhinoviral	 genome.	 The	 RNA	 concentration	 of	 each	 sample	 was	 calculated	 from	 a	
standard	curve	made	from	a	sample	of	known	copy	number	per	µl	(plasmid	standard).	
Plasmid	 standards	 were	 diluted	 to	 108	 copies	 per	µl	 and	 then	 a	 serial	 1:10	 dilution	
performed	up	to	100	copies	per	µl.		
For	 CXCL8	 and	 GAPDH	 1	µl	 of	 primer	 probe	 (Table	 2.6),	 10	µl	 of	 q-PCR	mastermix	
(Promega),	0.2	µl	CXR	(Promega),	7.8	µl	of	water	and	0.025	µg	cDNA	sample	or	1	µl	
plasmid	standard	was	added	to	each	well	of	a	384	well	plate.	For	RV	and	IFN-b,	1	µl	of	
each	 of	 diluted	 forward	 and	 reverse	 primers	 and	 probe,	 10	 µl	 q-PCR	 mastermix	
	 55	









Cell-free	 supernatants	 were	 collected	 (section	 2.9.1)	 and	 CXCL8	 or	 CCL5	 generation	
were	determined	by	ELISA.	100	µl	of	coating	antibodies	(Table	2.4)	diluted	in	coating	
buffer	(Table	2.2)	was	added	to	each	well	of	a	96	well	plate	with	high-binding	surface	
(Costar),	 and	 incubated	 at	 room	 temperature	 overnight.	 The	plate	was	washed	 four	
times	with	wash	buffer	(Table	2.2)	using	a	plate	washer	(Labtech	International),	then	
blocked	in	1%	albumin	(from	chicken	egg,	Sigma-Aldrich)	or	1%	BSA	(Sigma-Aldrich)	in	


















The	 R&D	 Systems	 IL-1b	 ELISA	 duo-set	 (Table	 2.3)	 was	 used	 to	 determine	 IL-1b	
generation	 in	 cell-free	 supernatants	 by	 ELISA,	 according	 to	 the	 manufacturer’s	
instructions.	96	well	plates	(Costar)	were	coated	overnight	using	100	µl	per	well	of	IL-1b	
coating	antibody,	diluted	to	4	µg/ml	in	PBS.	The	plate	was	washed	four	times	with	wash	




on	 a	 shaking	 platform	 before	 washing	 four	 times.	 100	 µl	 of	 biotinylated	 detection	
antibody,	 diluted	 to	 200	 ng/ml	 in	 1X	 reagent	 diluent,	 was	 added	 to	 each	 well,	 and	
incubated	at	room	temperature	on	a	shaking	platform	for	1.5	h.	The	plate	was	washed	
four	 times,	 and	 100	 µl	 of	 Streptavidin-HRP	 (R&D	 Systems),	 diluted	 1:40	 in	 reagent	
diluent	was	added	to	each	well,	and	incubated	in	the	dark	at	room	temperature	for	20	
minutes	on	a	shaking	platform.	After	washing	four	times,	100	µl	of	substrate	solution	








36	 cytokines	was	 determined	 using	 the	 R&D	 Systems	 cytokine	 array	 (Table	 2.3).	 All	






temperature	 for	 1	 h.	 Blocking	 buffer	 was	 removed	 from	 the	 dish	 and	 the	 sample	
	 57	
mixtures	 added	 to	 each	 well,	 before	 the	 membranes	 were	 incubated	 on	 a	 rocking	
platform,	 at	 4oC,	 overnight.	Membranes	 were	 then	washed	 three	 times	 in	 1X	wash	
buffer	for	10	minutes.	Streptavidin-HRP	was	diluted	1:2000	in	array	buffer	5,	and	3	ml	









Gels	were	assembled	 in	a	 running	 tank	 filled	with	1X	 running	buffer	 (Table	2.2).	Cell	
lysates	 (10	 µl)	 (section	 2.9.3)	 and	 prestained	 protein	 ladder	 (GeneFlow)	 were	
electrophoresed	 through	 the	 stacking	 gel	 at	 100	 V,	 increased	 to	 200	 V	 through	 the	
resolving	gel.	
2.16.2 Transfer	
Proteins	 were	 transferred	 onto	 0.22	 µm	 nitrocellulose	 membrane	 (Pall)	 using	 the	
Thermo	Scientific	Pierce	G2	Fast	Blotter.	Filter	paper	and	nitrocellulose	membrane	were	

































It	 is	 important	 to	 regulate	 these	 pathways	 to	 limit	 the	 inflammation	 produced	 in	
response	to	the	virus.	A	family	of	proteins	called	DUSPs	have	previously	been	found	to	
regulate	 the	MAPK	pathways	by	dephosphorylating	both	 the	 threonine	 and	 tyrosine	













It	 is	 well	 documented	 that	 epithelial	 cells	 respond	 to	 viral	 infection	 by	 secreting	
cytokines,	 such	 as	 CXCL8	 and	 CCL5.	 CXCL8	 is	 a	 neutrophil	 chemoattractant,	 its	
transcription	being	induced	by	NF-kB,	whereas	CCL5	production	is	mainly	 induced	by	
the	 IRFs.	 Therefore,	 secretion	 of	 these	 two	 molecules	 indicates	 that	 an	 immune	
response	has	been	 induced	and	can	give	an	 indication	of	which	 transcription	 factors	












CCL5	 release.	 Stimulation	 of	 PBECs	with	 the	 proinflammatory	 cytokine	 IL-1b	 caused	
release	of	CXCL8	but	not	CCL5,	for	which	two	out	of	six	donors	were	below	the	minimum	
detection	level.	This	was	in	keeping	with	the	literature	and	confirms	that	IL-1b	does	not	
activate	 the	 IRF	 and	 IFN	pathways.	 These	data	 confirm	 that	 under	 these	 conditions,	
































































inhibitors	 before	 stimulation	 with	 poly(I:C),	 as	 the	 greatest	 cytokine	 release	 was	
observed	in	response	to	this	stimulant.		
Inhibition	of	either	p38	or	JNK	dramatically	decreased	release	of	both	CXCL8	and	CCL5,	










secreted	protein	 level.	At	24	h	post	 infection,	RV1B	caused	a	small	 increase	in	CXCL8	
levels	 compared	 to	 the	media	 control,	 which	was	 unaffected	 by	 JNK	 inhibition,	 and	
inhibition	of	p38	caused	only	a	modest	downregulation	of	CXCL8	(Figure	3.3).		
The	response	of	PBECs	to	RV16	infection	was	similar,	with	only	a	small	effect	of	24	h	









Figure	 3.2	 Treatment	of	 PBECs	with	MAPK	 inhibitors	 decreases	 cytokine	 release	 in	
response	to	poly(I:C)	stimulation.		
PBECs	 were	 treated	 with	 MAPK	 inhibitor	 (20	 µM);	 U0126	 (ERK),	 PD98059	 (ERK),	
SB203580	 (p38),	 SB202190	 (p38)	 or	 SP600125	 (JNK);	 vehicle	 control;	 or	 untreated	
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Figure	 3.3	 Treatment	of	 PBECs	with	MAPK	 inhibitors	 decreases	 cytokine	 release	 in	
response	to	RV1B	infection.		












































































Figure	 3.4	 Treatment	of	 PBECs	with	MAPK	 inhibitors	 decreases	 cytokine	 release	 in	
response	to	RV16	infection.		







































































3.2.3 The	 Roles	 of	 the	 MAPKs	 in	 the	 Viability	 of	 PBECs	 in	 Response	 to	
Rhinoviral	Infection	











PBECs	 were	 treated	 with	 the	 indicated	 MAPK	 inhibitors	 (20	 µM),	 vehicle	 control	
(DMSO),	or	untreated	(media),	for	one	hour	prior	to	24	h	infection	with	RV1B	(MOI	3)	
(A)	or	RV16	(MOI	4)	(B).	Cell	titre	glo	cell	viability	assay	was	performed.	Data	shown	are	
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Figure	 3.6	 RV	 replication	 is	 decreased	 by	 p38	 inhibition	 and	 increased	 by	 JNK	
inhibition.		
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3.3 Activation	of	the	MAPK	Pathways	in	PBECs	














declined	over	 the	 rest	of	 the	 time	course,	 to	below	the	 level	 seen	 in	media	controls	
(Figure	3.8	A,	B,	C).	Infection	with	RV16	did	not	cause	the	initial	increase	in	phospho-
ERK	 levels,	 but	 from	 1	 h	 post	 infection	 levels	 gradually	 declined	 to	 an	 almost	















To	 investigate	this	 further,	PBECs	were	 infected	with	RV1B	and	RV16	and	cell	 lysates	








D).	 Therefore,	 JNK	 activation	was	 investigated	during	 the	 one	hour	 viral	 attachment	
period.	During	this	hour	JNK	was	phosphorylated	by	RV1B,	gradually	increasing	up	to	40	
min,	although	this	did	not	reach	statistical	significance,	before	declining	back	to	baseline	
(Figure	 3.12	 A).	 Phosphorylation	 was	 also	 observed	 in	 response	 to	 RV16	 infection,	
occurring	at	30	min	and	remaining	up	to	60	min	(Figure	3.12	B).	
As	rhinoviral	infection	activated	the	MAPKs	much	earlier	than	poly(I:C)	this	early	signal	
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of	band	density	normalised	 to	 the	actin	control	 for	each	sample,	n=3.	Significance	 is	
indicated	by	**	p	≤	0.01	 verses	unstimulated	 control	 (0	h)	 as	measured	by	one-way	
ANOVA,	with	Dunnett’s	post-test.	
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Figure	 3.10	 p38	 is	 activated	 by	 major	 and	 minor	 rhinoviral	 infection	 during	 viral	
attachment.		
PBECs	were	stimulated	with	RV1B	(A)	and	RV16	(B)	for	one	hour	during	viral	attachment	
































































of	band	density	normalised	 to	 the	actin	control	 for	each	sample,	n=3.	Significance	 is	
indicated	 by	 *	 p	 £	 0.05	 and	 ****	 p	 £	 0.0001	 verses	 unstimulated	 control	 (0	 h)	 as	
measured	by	one-way	ANOVA	with	Dunnett’s	post-test.		 	
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levels	 were	 measured	 using	 western	 blot.	 Representative	 blots	 are	 shown	 with	
densitometry	below.	Data	shown	are	mean	±	SEM	of	band	density	normalised	to	the	
actin	 control	 for	 each	 sample,	 n=3.	 Significance	 is	 indicated	 by	 *	 p	 £	 0.05	 verses	
unstimulated	control	(0	h)	as	measured	by	one-way	ANOVA,	with	Dunnett’s	post-test.		 	
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The	 phosphorylated,	 activated,	 p38	 and	 JNK	MAPK	 signals	 were	 lost	 not	 long	 after	
activation	in	response	to	stimulation	with	IL-1b	or	poly(I:C)	or	infection	with	rhinovirus	
(Figures	 3.9	 –	 3.12).	 Phosphorylated	 proteins	 can	 be	 regulated	 through	
dephosphorylation	 or	 degradation.	 To	 determine	 the	 role	 of	 phosphatases	 in	 the	
regulation	of	p38	and	JNK	signalling	in	response	to	rhinovirus,	PBECs	were	treated	with	
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ERK,	 p38,	 and	 JNK	 and	 total	 actin	 levels	 were	 measured	 using	 western	 blot.	
Representative	blots	are	shown	in	A	with	densitometry	in	B,	C	and	D.	Data	shown	are	
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opposite,	 increased	 viral	 RNA.	 The	 increased	 viral	 replication	 in	 the	 absence	 of	 JNK	
signalling	was	not	found	to	be	due	to	changes	in	IFN-b	production.	These	data	suggest	
that	 the	 p38	 and	 JNK	 pathways	 have	 important	 roles	 in	 the	 response	 of	 PBECs	 to	
rhinoviral	infection.		
JNK	 and	 p38	 are	 activated	 in	 response	 to	 innate	 immune	 stimuli	 in	 PBECs.	 TLR3	
activation,	 by	 poly(I:C),	 leads	 to	 activation	 of	 both	 pathways	 with	 similar	 timings,	
peaking	 2	 h	 post	 stimulation.	 Stimulation	with	 the	 inflammatory	 cytokine	 IL-1b	 also	
leads	to	activation	of	both	pathways,	with	an	earlier	peak	activation	of	30	minutes	post	
stimulation.	 In	 response	 to	 rhinoviral	 infection,	MAPK	activation	 is	undetectable,	 the	
phosphorylation	seen	by	western	blot	being	due	to	an	unknown	molecule	present	in	the	










To	 the	 best	 of	 my	 knowledge,	 these	 proteins	 have	 not	 yet	 been	 studied	 in	 PBECs.	
Therefore,	to	ensure	that	the	DUSPs	were	being	expressed	in	PBECs,	RT-PCR	was	used	
to	measure	the	mRNA	expression	of	DUSPs	1,	2,	4	and	10	and	a	GAPDH	control.	The	
regulation	of	 expression	of	 these	DUSPs	was	 investigated	 in	 response	 to	 stimulation	
with	poly(I:C)	or	IL-1b	over	24	h.	All	of	the	DUSPs	studied	were	expressed	at	the	mRNA	
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3.6 Expression	and	Regulation	of	DUSP1	in	PBECs	













of	 rhinoviral	 infection,	 and	 the	 MAPKs	 have	 been	 shown	 to	 be	 able	 to	 induce	








3)	 (C)	 or	 RV16	 (MOI	 4)	 (D)	 over	 24	 hours.	 mRNA	 was	 collected	 at	 the	 time	 points	
indicated	and	ΔΔCt	qRT-PCR	performed	for	DUSP1	and	a	GAPDH	control.	Data	shown	
are	mean	±	SEM,	n=3,	 fold	change	compared	to	unstimulated	control.	Significance	 is	
indicated	 by	 *	 p	 ≤	 0.05	 verses	 unstimulated	 control	 (0	 h)	 as	measured	 by	 one-way	
ANOVA,	with	Dunnett’s	post-test,	on	the	ΔΔCt	values.	
	 	










































































































































performed	 for	DUSP1	and	a	GAPDH	control.	Data	 shown	are	mean	±	SEM,	n=3,	 fold	
change	 compared	 to	 unstimulated	 control.	 Significance	 was	 measured	 by	 one-way	
ANOVA,	with	Dunnett’s	post-test	on	the	ΔΔCt	values.	









































































































































3.6.3 DUSP1	 Protein	 Expression	 and	 Regulation	 in	 PBECs	 in	 Response	 to	
Rhinoviral	Infection	
Although	DUSP1	mRNA	was	not	 regulated	 in	 response	 to	 rhinoviral	 infection	 (Figure	












translationally	 regulate	 DUSP1	 (Brondello	 et	 al.,	 1999).	 Therefore,	 the	 protein	
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Data	 shown	 are	mean	 ±	 SEM	of	 band	 density	 normalised	 to	 the	 actin	 control	 for	 each	
sample,	 n=3.	 Significance	 was	measured	 verses	 unstimulated	 control	 (0	 h)	 by	 one-way	
ANOVA,	with	Dunnett’s	post-test.	
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more	 dramatic,	 with	 a	 maximum	 increase	 of	 70-fold	 at	 6	 h	 post	 stimulation.	











donor.	 Data	 shown	 are	 mean	 ±	 SEM	 band	 density	 normalised	 to	 actin	 control	 and	
untreated	 control	 for	 each	 sample	 (B).	 Significance	 is	 indicated	by	*	p	≤	0.05	 versus	
untreated	control	as	measured	by	two-way	ANOVA	with	Dunnett’s	post-test	on	the	ΔΔCt	
values	(A)	or	band	density	(B).		






































































  2   4   6  24   2   4   6  24   2   4   6  24







rhinoviral	 infection	 did	 not	 alter	 expression	 of	 DUSP1	 at	 the	mRNA	 or	 protein	 level	
(Figures	3.18	and	3.21),	DUSP1	could	be	regulated	by	post-translational	modifications.	
Thus,	 the	 level	 of	 Ser-359	 phosphorylated	DUSP1	 protein	 in	 PBECs	was	 investigated	
using	western	blot	to	determine	if	DUSP1	was	phosphorylated	at	baseline	and	whether	
this	 was	 regulated	 in	 response	 to	 infection	 with	 RV1B	 or	 RV16	 or	 stimulation	 with	
poly(I:C)	or	IL-1b.	
No,	or	 little,	phosphorylated	DUSP1	was	detected	at	baseline	 in	PBECs	 (Figure	3.24).	
Phospho-DUSP1	 levels	 gradually	 increased	 in	 response	 to	 stimulation	 with	 IL-1b,	
peaking	around	4	h	post-stimulation	before	declining	back	to	baseline	by	24	h	(Figure	
3.24	 A).	 Poly(I:C)	 stimulation	 also	 caused	 a	 gradual	 rise	 in	 phospho-DUSP1	 levels,	
peaking	later,	at	8	h	post-stimulation,	before	declining	back	to	baseline	(Figure	3.24	B).	
Infection	with	either	 rhinoviral	 strain	 caused	an	early	 increase	 in	phosphorylation	of	
DUSP1,	with	a	peak	at	1	h	before	declining	back	to	baseline,	and	a	second	peak	at	24	h	





















RV16,	 and	 n=4	 for	 IL-1β	 and	 RV1B.	 Significance	 is	 indicated	 by	 *	 p	 £	 0.05	 verses	
unstimulated	control	(0	h)	as	measured	by	one-way	ANOVA,	with	Dunnett’s	post-test.	
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actin	 control	 for	 each	 sample,	 n=3.	 Significance	 was	 measured	 verses	 unstimulated	
control	(0	h)	by	one-way	ANOVA,	with	Dunnett’s	post-test.	
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DUSP10	 (Qian	 et	 al.,	 2009)	 (Section	 1.5.4),	 was	 also	 taken	 forward	 for	 further	
investigation	into	the	response	to	rhinoviral	infection.		














the	pattern	seen	 in	phosphorylated	DUSP1	 levels	 in	 response	 to	RV	 infection	 (Figure	
3.24	C	and	D).		
To	the	best	of	our	knowledge,	the	pathways	responsible	for	inducing	DUSP10	expression	
have	 not	 previously	 been	 identified.	 The	 MAPK	 pathways	 are	 capable	 of	 inducing	
transcription	of	DUSPs	1,	2	and	4	(Ananieva	et	al.,	2008).	Thus,	to	investigate	whether	






Figure	 3.26	 DUSP10	 transcription	 does	 not	 change	 in	 response	 to	major	 or	minor	
rhinoviral	infection	or	stimulation	with	poly(I:C)	or	IL-1β.	
PBECs	were	stimulated	with	IL-1β	(100	ng/ml)	(A),	poly(I:C)	(25	µg/ml)	(B),	RV1B	(MOI	
3)	 (C)	 or	 RV16	 (MOI	 4)	 (D)	 over	 24	 hours.	 mRNA	 was	 collected	 at	 the	 time	 points	
indicated	and	ΔΔCt	qRT-PCR	performed	for	DUSP10	and	a	GAPDH	control.	Data	shown	




















































































































































mRNA	was	 collected	 at	 the	 time	 points	 indicated	 and	 ΔΔCt	 qRT-PCR	 performed	 for	
DUSP10	 and	 a	 GAPDH	 control.	 Data	 shown	 are	 mean	 ±	 SEM,	 n=3,	 fold	 change	
normalised	to	GAPDH	and	unstimulated	control.	Significance	was	measured	by	one-way	
ANOVA,	with	Dunnett’s	post-test,	on	the	ΔΔCt	values.	







































































3.8.2 DUSP10	 Protein	 Expression	 and	 Regulation	 in	 PBECs	 in	 Response	 to	
Rhinoviral	Infection	
The	expression	of	DUSP10	was	then	examined	further,	in	order	to	determine	whether	







the	 expression	 then	 declined	 slightly,	 although	 this	 was	 not	 statistically	 significant.	
Unlike	the	mRNA	expression,	this	decreased	expression	did	not	return	to	baseline	by	24	
h	(Figure	3.28	C	and	D).			
Expression	 of	 DUSP10	 over	 the	 1	 h	 viral	 attachment	 phase	 was	 then	 investigated.	
Addition	of	RV16	did	not	affect	the	protein	level	of	DUSP10	during	this	hour	(Figure	3.29	
B).	 Intriguingly,	stimulation	with	RV1B	consistently	caused	a	reduction	 in	the	 level	of	
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has	 not	 previously	 been	 examined.	 The	mRNA	 and	 protein	 expression	 of	DUSP10	 in	
PBECs	were	measured	over	24	h	of	1	to	100	nM	dexamethasone	treatment.	Similarly	to	
the	 results	 for	 DUSP1	 expression	 (Figure	 3.23),	 two	 out	 of	 three	 PBEC	 donors	were	












and	a	GAPDH	control.	Data	 shown	are	mean	±	SEM,	n=3,	 fold	 change	normalised	 to	
GAPDH	and	untreated	control	(A).	Total	DUSP10	and	actin	protein	levels	were	measured	
using	 western	 blot.	 A	 representative	 blot	 is	 shown	 with	 densitometry	 below.	 Data	
shown	are	mean	±	SEM,	n=3,	band	density	normalised	to	actin	control	and	untreated	
control	 for	 each	 sample	 (B).	 Significance	 is	 indicated	by	*	p	≤	0.05	 versus	untreated	
control	as	measured	by	two-way	ANOVA	with	Dunnett’s	post-test	on	the	ΔΔCt	values	
(A)	or	band	density	(B).	
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response	 (Section	 1.5.6).	 Although	 it	 is	 most	 commonly	 thought	 to	 act	 on	 the	 ERK	
pathway,	its	effect	on	innate	immune	signalling	is	controversial,	with	some	suggesting	
it	has	a	negative	regulatory	role	and	others	suggesting	it	has	a	positive	(Al-Mutairi	et	al.,	














Figure	 3.31	 DUSP4	 transcription	 does	 not	 change	 in	 response	 to	 major	 or	 minor	
rhinoviral	infection	or	stimulation	with	poly(I:C)	or	IL-1β.	
PBECs	were	stimulated	with	IL-1β	(100	ng/ml)	(A),	poly(I:C)	(25	µg/ml)	(B),	RV1B	(MOI	

















































































































































the	 synthetic	 TLR3	 ligand	 poly(I:C),	 or	 the	 inflammatory	 cytokine	 IL-1b.	 Inhibitors	 of	
these	 pathways	 were	 utilised	 to	 determine	 their	 role	 in	 the	 response	 of	 PBECs	 to	
rhinoviral	infection,	and	in	rhinoviral	replication.	
Potential	 regulators	 of	 these	 pathways,	 the	 DUSP	 family,	 were	 then	 examined	 to	
determine	whether	 they	were	 expressed	 in	 PBECs	 and	whether	 this	 expression	was	
regulated	by	rhinoviral	infection.	
3.10.2 The	Roles	of	the	MAPKs	in	Viral	Infection	
The	 MAPK	 signalling	 pathways	 are	 known	 to	 be	 activated	 by	 rhinoviral	 infection	
(Dumitru	et	al.,	2006,	Griego	et	al.,	2000,	Lau	et	al.,	2008,	Newcomb	et	al.,	2008,	Wang	
et	al.,	2006),	and	previous	inhibitor	studies	have	shown	the	importance	of	p38	and	ERK	
in	 the	 innate	 immune	 response	 to	 rhinovirus	 (Griego	 et	 al.,	 2000,	 Liu	 et	 al.,	 2008a).	
However,	much	of	this	work	has	been	done	in	cell	lines,	and	the	roles	of	these	pathways	
in	the	response	of	PBECs	to	rhinoviral	infection	have	not	been	well	characterised.	Figure	
3.1	 demonstrates	 that	 the	 innate	 immune	 pathways	 are	 being	 activated	 by	 TLR3	
stimulation	and	rhinoviral	infection,	leading	to	the	secretion	of	inflammatory	proteins.	
RV16	infection	induced	a	much	smaller	response	than	RV1B,	with	no	detectable	CXCL8	








decrease	 in	CXCL8	 release	after	24	h	of	poly(I:C)	 stimulation.	As	discussed	 in	 section	
1.3.4,	Gern	et	al.	have	previously	demonstrated	that	treatment	of	PBECs	with	SB203580	
decreased	CXCL8	release	in	response	to	16	h	of	poly(I:C)	treatment	(Gern	et	al.,	2003).	




24	h	of	 rhinoviral	 infection,	although	after	48	h	 infection	CXCL8	mRNA	and	secreted	
protein	 was	 decreased	 by	 p38	 or	 JNK	 inhibition.	 Previous	 studies	 have	 shown	 that	
treatment	 of	 BEAS-2B	 cells	 with	 SB203580	 caused	 a	 decrease	 in	 CXCL8	 release	 in	
response	to	rhinoviral	infection	at	40	h	(Liu	et	al.,	2008a)	or	72	h	(Griego	et	al.,	2000).	
One	potential	reason	that	the	effect	of	the	inhibitors	is	not	visible	until	later	time	points	




Roberts,	 Personal	 Communication,	 Jakiela	 et	 al.,	 2008,	 Lopez-Souza	 et	 al.,	 2009),	









IRF	proteins	 inducing	CCL5	 transcription.	 Furthermore,	a	decrease	 in	CCL5	 release	 in	
response	to	poly(I:C)	was	not	seen	in	the	work	of	Gern	et	al.	in	2003	when	BEAS-2B	cells	


















decrease	 in	 CCL5	 release.	 CCL5	 is	 an	 interferon	 stimulated	 gene,	 upregulated	 by	 RV	
infection	of	PBECs	 (Khaitov	et	 al.,	 2009,	 Lin	et	 al.,	 1999).	Addition	of	 interferon-b	 to	
PBECs	significantly	reduces	replication	of	RV16	(Wark	et	al.,	2005).	Thus,	the	increase	in	
rhinoviral	 replication	 when	 JNK	 is	 inhibited	 could	 be	 due	 to	 a	 decrease	 in	 the	 IFN	
response.	 The	 JNK	 pathway	 has	 previously	 been	 reported	 to	 phosphorylate	 IRF3	 in	
response	to	poly(I:C)	signalling,	although	this	study	was	performed	in	the	293T	cell	line	
using	 over	 expression	 techniques	 (Zhang	 et	 al.,	 2009).	 This	 is	 not	 supported	 by	 the	
results	of	this	study,	where	JNK	inhibition	increased	the	expression	of	IFN-b	in	response	






p38	 inhibition	 also	 led	 to	 a	 decrease	 in	 cytokine	 release	 a	 similar	 effect	 would	 be	
expected	in	response	to	p38	inhibition.	It	is	possible	that	necessity	for	p38	in	the	viral	








virus	 (Marchant	 et	 al.,	 2010).	 Coxsackie	 virus	 B3	 is	 a	member	 of	 the	 Picornaviridae	
family,	like	rhinovirus,	and	therefore	has	a	similar	life	cycle.	The	Marchant	study	went	
on	to	determine	the	mechanism	of	p38	involvement	in	influenza	virus	replication.	They	




importance	 and	 requires	 further	 investigation.	 If	 p38	 is	 necessary	 for	 rhinoviral	
replication,	 then	 regulation	 of	 p38	 has	 the	 potential	 for	 use	 as	 a	 future	 anti-viral	
treatment.	This	work	should	be	taken	forward	with	TCID50	assays	to	determine	whether	
the	difference	 in	 the	 level	 of	 viral	 RNA	 translates	 into	 a	 difference	 in	 the	 release	of	
productive	viral	particles.		















response	 of	 PBECs	 to	 rhinoviral	 infection,	 including	 inducing	 inflammatory	 cytokine	
release	and	possibly	inducing	IFN	release.	The	p38	MAPK	may	also	have	an	important	
role	 in	 the	 rhinoviral	 life	 cycle.	 Thus,	 the	 investigation	 into	 the	 regulation	 of	 these	
pathways	 is	of	 importance.	One	 limitation	of	 this	 study	 is	 the	use	of	 small	molecule	
inhibitors,	which	have	some	off-target	effects	(Bain	et	al.,	2007).	In	future,	it	would	be	
important	 to	 confirm	 these	 findings	 using	 siRNA	 knock	 down	of	 the	MAPK	proteins.	
siRNA	 knock	 down	 in	 PBECs	 of	 p38	 or	 c-Jun,	 the	 JNK	 target,	 have	 been	 published	
previously	 and	 were	 shown	 to	 reduce	 CXCL8	 production	 in	 PBECs	 in	 response	 to	
lysophosphatidic	acid	(Saatian	et	al.,	2006).	 It	would	also	be	of	 interest	to	determine	




































at	 4oC	 to	 allow	 attachment	 but	 prevent	 internalisation.	 Then,	when	moved	 to	 37oC,	




signalling	 to	 the	 surrounding	 cells.	 This	 could	 be	 further	 investigated	 using	
immunofluorescence	 techniques,	 imaging	phosphorylated	MAPKs	 and	 viral	 capsid	 or	









2013).	 The	 presence	 of	 these	 molecules	 may	 also	 vary	 between	 batches	 of	 virus,	
depending	on	the	amount	of	cell	death	caused	by	infection.	The	MAPKs	are	known	to	









did	 not	 lead	 to	 any	measurable	 effect	 on	 cytokine	 production	 or	 release,	 therefore,	
would	not	affect	the	results	of	the	inhibitor	experiments.	In	future,	it	will	be	important	
to	 use	 purified	 viral	 stocks,	made	 using	 ultracentrifugation,	which	 is	 currently	 being	
optimised	in	our	group.		
MAPKs	 can	 be	 regulated	 in	 many	 different	 ways,	 including	 subcellular	 localisation,	
availability	 of	 scaffold	 proteins	 and	 post-translational	 modifications,	 as	 well	 as	
dephosphorylation	 (Reviewed	 in:	 Raman	 et	 al.,	 2007).	 Treatment	 of	 PBECs	 with	 a	
general	phosphatase	 inhibitor	 caused	an	 increase	 in	activation	of	both	p38	and	 JNK,	










expressed	 by	 innate	 immune	 cells,	 such	 as	 mast	 cells,	 eosinophils,	 neutrophils	 and	
macrophages,	and	no	expression	was	detected	in	primary	human	bronchial	epithelial	











epithelial	 cells,	 compared	 to	macrophages	or	 fibroblasts,	or	 it	 could	be	due	 to	 some	









DUSP1	 mRNA	 expression	 has	 previously	 been	 found	 to	 be	 increased	 by	 poly(I:C)	
stimulation	in	a	bronchial	epithelial	cell	line,	NCI-H292,	with	around	a	2-fold	increase	1	
h	post	stimulation	(Golebski	et	al.,	2014).	 In	this	study,	DUSP1	mRNA	expression	was	
significantly	 increased	 by	 poly(I:C)	 stimulation	 much	 later	 on,	 at	 24	 h,	 with	 non-
significant,	 but	 consistent,	 increases	 of	 around	 2-fold	 also	 observed	 at	 4-6	 h	 post	
stimulation.	The	changes	in	DUSP1	mRNA	were	not	translated	into	an	increase	in	DUSP1	
protein	within	24	h.	However,	it	is	possible	that	changes	in	DUSP1	at	the	protein	level	







comparing	 gene	expression	 from	nasal	 scrapings	of	 patients	 infected	with	RV16	and	
sham	infected,	where	infection	did	not	alter	DUSP1	expression	(Proud	et	al.,	2008).		
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p38	 and	 ERK	MAPKs	 have	 previously	 been	 shown	 to	 induce	 transcription	 of	 DUSP1	
through	 the	 MSK	 proteins	 (Ananieva	 et	 al.,	 2008).	 In	 this	 study,	 inhibition	 of	 p38	









infection	 than	 poly(I:C)	 stimulation.	 This	 indicates	 that	 an	 early,	 TLR3	 independent,	
signalling	 pathway	 is	 induced	 upon	 rhinoviral	 binding	 and	 internalisation,	 which	 is	
leading	to	DUSP1	phosphorylation.	It	has	previously	been	shown	that	ERK	is	capable	of	
phosphorylating	DUSP1	(Brondello	et	al.,	1999).	As	ERK	activation	was	seen	 in	media	



















that	 at	 8	 h	 and	 48	 h	 post	 RV16	 infection	 the	 expression	 of	 many	 genes	 were	




been	 associated	 with	 regulating	 IRF3	 phosphorylation	 and	 the	 antiviral	 response	 in	
influenza	 infection	 (James	 et	 al.,	 2015).	 If	 DUSP10	 has	 a	 role	 in	 anti-viral	 pathways,	
rhinovirus	may	 have	 developed	 a	mechanism	 to	 interfere	with	 this	 by	 degrading	 or	
down	regulating	DUSP10.	Many	viruses	 target	host	proteins	 for	degradation	 through	
host	pathways,	utilising	host	ubiquitin	ligases	or	expressing	their	own	(Barro	and	Patton,	
2005,	Okumura	 et	 al.,	 2008).	 However,	 preliminary	 data	 using	MG132	 suggests	 that	
inhibition	 of	 proteosomal	 degradation	 does	 not	 stop	 the	 loss	 of	 DUSP10	 protein	 30	




and	230,	 leading	 to	 stabilisation	of	 the	protein	 (Benavides-Serrato	et	 al.,	 2014).	 This	
event	was	linked	to	the	mTORC	family	of	kinases,	a	group	of	proteins	involved	in	the	
PI3K	signalling	pathway.	As	discussed	above,	the	PI3K	pathway	has	been	found	to	be	
activated	 upon	 rhinoviral	 infection	 (Section	 1.3.4).	 It	 would	 be	 of	 interest	 to	 know	
whether	DUSP10	is	regulated	by	phosphorylation	upon	rhinoviral	infection,	similarly	to	
DUSP1.	Attempts	were	made	to	investigate	this.	As	no	antibody	against	phosphorylated	
DUSP10	 is	 commercially	 available,	 immunoprecipitation	 of	 DUSP10	 from	 PBECs	 was	
attempted,	but	was	unsuccessful	(data	not	shown).	Utilisation	of	the	PhosTag	(Wako)	
molecule,	which	 binds	 to	 phosphorylated	 proteins,	 increasing	 their	weight,	 enabling	
separation	of	phosphorylated	and	non-phosphorylated	proteins	by	western	blot	was	
also	unsuccessful	(data	not	shown).		





















and	 JNK,	 play	 potentially	 important	 roles	 in	 rhinoviral	 infection	 of	 PBECs.	 TLR3	
stimulation	induces	activation	of	the	p38	and	JNK	MAPK	proteins,	and,	while	activated	
protein	 is	 undetectable	 in	 response	 to	 RV,	 inhibition	 of	 the	 pathways	 has	 an	 effect,	
demonstrating	 that	 they	 are	being	 activated.	 Both	pathways	 contribute	 towards	 the	
inflammatory	response,	inducing	production	and	release	of	neutrophil	and	eosinophil	
chemoattractants.	 They	 also	 play	 opposing	 roles	 in	 rhinoviral	 replication:	 p38	 being	
necessary	 for	 replication	 and	 JNK	 limiting	 it.	 The	mechanisms	 for	 this	 remain	 to	 be	
elucidated,	although	JNK	does	not	seem	to	be	acting	through	induction	of	IFN-b.	
Two	proteins	previously	found	to	have	important	roles	in	regulating	p38	and	JNK,	DUSP1	





may	 be	 regulated,	 which	 remain	 to	 be	 investigated,	 for	 example	 oxidation	 and	
acetylation.	 The	 differences	 in	 regulation	 of	 these	 proteins	 suggests	 they	may	 have	
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different	 roles	 in	 regulating	 the	 response	 to	 RV	 infection.	 This	 will	 be	 further	
investigated	in	chapter	4.		
These	findings	are	summarised	in	figure	3.32.	



















inflammatory	 response	 of	 PBECs	 to	 rhinoviral	 infection.	 Therefore,	 two	 DUSPs	















prolonged	 in	knock	out	BMDMs,	but	activated	p38	and	 JNK	 levels	were	comparable.	
Type	I	 IFN	expression	was	also	 increased	 in	knock	out	BMDMs	when	stimulated	with	
poly(I:C),	or	the	RIG-I	substrate	5’-tri-phosphorylated	double-stranded	RNA,	or	infected	
with	vesicular	stomatitis	virus	or	sendai	virus.	This	increase	in	IFN	production	correlated	




















of	 DUSP1	 in	 rhinoviral	 infection	 of	 PBECs,	 siRNA	 knock	 down	 of	 DUSP1	 protein	was	
attempted.	 BEAS-2B	 cells	 were	 initially	 used	 to	 optimise	 the	 siRNA	 knock	 down.	
Transfection	of	BEAS-2Bs	with	four	different	siRNA	targeting	DUSP1,	listed	in	table	2.7,	
did	not	 lead	 to	measurable	differences	 in	DUSP1	protein	 levels	after	24	h	 treatment	
(data	not	shown)	or	48	h	treatment	(Figure	4.1	A).	DUSP1	siRNA	number	4	had	been	
optimised	 in	 BEAS-2B	 cells	 previously	 by	 another	 group	 (S.	 V.	 Shah,	 Personal	
Communication),	however	in	this	study,	this	was	unsuccessful	in	BEAS-2Bs,	HeLa	Ohio,	
and	PBECs.	DUSP1	mRNA	levels	were	also	measured	and	no	differences	were	detected	
between	 control	 and	 DUSP1	 siRNA	 treatments	 (data	 not	 shown).	 CXCL8	 release	 in	
response	to	poly(I:C)	stimulation	was	also	quantified,	to	investigate	whether	the	DUSP1	
siRNA	 treatment	 had	 measurable	 consequences	 despite	 uncertain	 knock	 down.	 No	
differences	 in	 CXCL8	 production	 were	 observed	 between	 control	 and	 DUSP1	 siRNA	
treatments	(Figure	4.1	B).	DUSP1	knock	down	was	also	attempted	in	PBECs	using	all	four	







and	 primary	 cells.	 Viromer	 Blue	 was	 also	 selected	 as	 it	 has	 been	 designed	 for	
transfection	 of	 hard-to-transfect	 primary	 cells.	 However,	 neither	 led	 to	 measurable	
knock	down	of	DUSP1	mRNA	or	protein	levels	(data	not	shown).	All	conditions	tested	
are	listed	in	table	4.1.		
Dexamethasone	 treatment	 causes	 upregulation	 of	 DUSP1	 protein	 expression	 (Figure	
3.23).	Any	small	differences	 in	DUSP1	expression	caused	by	siRNA	treatment	may	be	
more	 detectable	 when	 DUSP1	 is	 upregulated	 by	 dexamethasone.	 However,	 DUSP1	
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Un     M    Ctrl  1 Un   Ctrl   2     3 Un   Ctrl  4
A
B



























1	 2	 3	 4	
PBECs	 1X	Lipo.	24	h		 X	 		 X	 		
1X	Lipo.	48	h	 		 X	 X	 X	
2X	Lipo.	24	h	 		 X	 		 		
2X	Lipo.		48	h		 		 X	 X	 		
1X	siRNA	24	h	 		 		 		 		
1X	siRNA	48	h	 		 X	 		 X	
2X	siRNA	48	h	 		 X	 		 X	
PIC	Stimulation	 X	 		 X	 		
Different	Confluencies	 X	 X	 X	 		
BEAS-2B	 1X	Lipo.	24	h		 X	 		 		 X	
1X	Lipo.	48	h	 X	 		 X	 X	
2X	Lipo.	24	h	 X	 X	 		 X	
2X	Lipo.		48	h		 X	 X	 X	 X	
1X	siRNA	24	h	 		 X	 		 X	
1X	siRNA	48	h	 X	 X	 X	 X	
2X	siRNA	24	h	 		 		 		 X	
2X	siRNA	48	h	 X	 		 X	 X	
Mission	1X	siRNA	 X	 X	 X	 		
Mission	2X	siRNA	 X	 X	 X	 		
Viromer	1X	siRNA	 X	 X	 X	 		
Viromer	2X	siRNA	 X	 X	 X	 		
PIC	Stimulation	 X	 		 		 X	
Dex.	Treatment	 		 X	 X	 X	
Different	Confluencies	 X	 X	 X	 X	
Different	Media	 X	 X	 X	 X	
HeLa	Ohio	 2X	Lipo.	24	h		 X	 		 X	 X	
2X	Lipo.	48	h	 		 		 X	 X	
1X	siRNA	24	h	 X	 		 X	 X	
1X	siRNA	48	h	 		 		 X	 X	







In	 order	 to	 determine	 the	 role	 of	 DUSP10	 in	 regulating	 the	 response	 of	 PBECs	 to	



































































replication,	 and	 increased	 interferon	 production	 (James	 et	 al.	 2015).	 The	 effect	 of	
reduced	 DUSP10	 protein	 levels	 on	 replication	 of	 rhinovirus	 was	 investigated.	 After	
treatment	with	DUSP10	or	control	siRNA,	replication	of	both	RV1B	and	RV16	in	PBECs	
was	determined	by	qRT-PCR	with	primers	specific	 for	rhinoviral	RNA.	Both	RV1B	and	
RV16	 replicated	 in	 PBECs,	 although	 the	 level	 of	 replication	 varied	 greatly	 between	
donors,	and	the	level	of	replication	was	unaffected	by	treatment	with	either	control	or	
DUSP10	siRNA	(Figure	4.3).		
The	 effect	 of	 knocking	 down	 DUSP10	 on	 IFN	 production	 was	 then	 investigated.	
Treatment	 with	 control	 siRNA	 caused	 increases	 in	 IFN-b	 mRNA	 levels	 and	 cytokine	






stimulated	gene	CCL5	 in	 response	 to	either	 strain	of	 rhinovirus	 (Figure	4.5	A	and	B).	
However,	in	response	to	stimulation	with	poly(I:C),	DUSP10	siRNA	treatment	caused	a	
statistically	significant	decrease	in	CCL5	release	compared	to	control	siRNA	treatment.	











































































4)	 (C)	 for	 4	 h.	mRNA	was	 collected	 and	 qRT-PCR	performed	 for	 IFN-β	 and	 a	GAPDH	
control.	 Data	 shown	 are	 mean	 ±	 SEM	 normalised	 to	 the	 GAPDH	 control,	 n=3.	
Significance	between	control	and	DUSP10	siRNA	was	measured	by	paired	t-test.	


















































































































4)	 (C)	 for	24	h.	Supernatant	was	collected	and	ELISA	used	to	measure	 the	release	of	
CCL5.	 Data	 shown	 are	 mean	 ±	 SEM,	 n=4	 for	 poly(I:C)	 and	 3	 for	 RV1B	 and	 RV16.	
Significance	between	DUSP10	and	control	siRNA	treatment	is	indicated	by	*	p	≤	0.05	as	
measured	by	paired	t-test.	




























































DUSP10	 knock	 out	 mice	 have	 previously	 been	 found	 to	 show	 increased	 cytokine	
generation	in	response	to	influenza	infection,	as	well	as	other	innate	immune	stimuli,	
such	as	poly(I:C),	LPS,	and	bacterial	infection	(Section	1.5.4).	Thus,	the	effect	of	DUSP10	
knock	 down	 on	 cytokine	 generation	 in	 PBECs	 in	 response	 to	 rhinoviral	 infection,	 or	






to	control	siRNA	treatment	(Figure	4.6	B).	 In	addition,	CXCL8	release	 is	not	 increased	
with	DUSP10	knock	down	in	poly(I:C)	treated	cells	(Figure	4.7	B).		
In	 response	 to	 stimulation	 with	 IL-1β,	 cells	 treated	 with	 DUSP10	 siRNA	 showed	
consistently	 higher	 CXCL8	mRNA	 levels	 than	 untransfected	 or	 control	 siRNA	 treated	










CXCL8	 and	 a	 GAPDH	 control.	 Data	 shown	 mean	 ±	 SEM	 normalised	 to	 GAPDH	 and	
unstimulated	 (media)	 control,	 n=4	 for	 A	 and	 B,	 and	 n=3	 for	 C	 and	 D.	 Significance	
between	DUSP10	and	control	siRNA	treatments	was	measured	by	paired	t-test.	
	 	



































































































































measure	 the	 release	 of	 CXCL8.	 Data	 shown	 are	 mean	 ±	 SEM,	 n=3,	 normalised	 to	



































































































PBECs	 with	 confirmed	 DUSP10	 knock	 down	 were	 treated	 with	 a	 range	 of	 IL-1β	
concentrations.	 At	 each	 concentration	 of	 IL-1β,	 DUSP10	 knock	 down	 consistently	
resulted	in	an	increase	in	CXCL8	mRNA	levels,	with	significant	differences	in	cells	treated	
with	10	and	100	ng/ml	(Figure	4.9	A).	However,	when	measured	by	ELISA,	this	difference	





















































































PBECs	were	 treated	with	DUSP10	 or	 control	 siRNA	 (Ctrl)	 (100	 nM)	 for	 48	 h	 prior	 to	
stimulation	 with	 IL-1β	 (1-100	 ng/ml)	 for	 24	 h.	 mRNA	 was	 collected	 and	 qRT-PCR	
performed	for	CXCL8	and	a	GAPDH	control.	Data	shown	are	each	donor	normalised	to	
the	 GAPDH	 control	 and	 unstimulated	 (0	 ng/ml)	 Ctrl	 cells	 n=4	 (A).	 Supernatant	 was	
collected	 and	 ELISA	 used	 to	 measure	 the	 release	 of	 CXCL8,	 n=3	 (B).	 Significance	 is	
indicated	 by	 *	 p	 ≤	 0.05	 as	 measured	 by	 two-way	 ANOVA	 with	 Sidak's	 post-test,	 to	
compare	between	control	and	DUSP10	siRNA	at	each	dose.	




















































































































that	 any	 increase	 in	 CXCL8	 production	 in	 DUSP10	 knock	 down	 in	 response	 to	 IL-1b	
(Figure	4.9	and	4.10)	would	be	due	to	increased	MAPK	activation.	This	was	investigated	







48	 h	 before	 stimulation	 with	 IL-1b	 (100	 ng/ml)	 and	 cell	 lysate	 collected	 at	 30	min.	
Phosphorylated	p38	and	JNK	and	total	actin	levels	were	measured	using	western	blot.	A	
representative	blot	 is	shown	(A)	with	densitometry	below	(B	and	C).	Data	shown	are	
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for	 36	 human	 cytokines,	 chemokines	 and	 proteins	 known	 to	 be	 upregulated	 by	
inflammation,	enabling	a	broad	view	of	the	effect	of	the	loss	of	DUSP10.		
IL-1b	 stimulation	 caused	 an	 upregulation	 in	 the	 release	 of	 several	 cytokines:	 CXCL1,	
CXCL10,	G-CSF,	GM-CSF,	IL-1b,	IL-6,	and	CXCL8.	IL-1ra	was	secreted	by	PBECs,	but	the	
level	 was	 unaffected	 by	 IL-1b	 stimulation.	 Two	 molecules	 with	 roles	 in	 airway	
remodelling	were	secreted	by	PBECs	in	both	stimulated	and	unstimulated	cells:	MIF	and	
Serpin1	 (Chen	 et	 al.,	 2010,	Oh	 et	 al.,	 2002).	 CXCL12	 release	was	 decreased	by	 IL-1b	
stimulation	 compared	 to	 media	 only	 controls.	 (Table	 4.2).	 	 Some	 proteins	 that	 are	
known	 to	be	 released	by	epithelial	 cells	 in	 response	 to	 rhinoviral	 infection	or	dsRNA	
were	not	released	in	response	to	IL-1b,	including:	CXCL1,	ICAM-1,	IL-1a,	IL-2,	IL-16,	IL-
17E	and	IL-18	(Beale	et	al.,	2014,	Papadopoulos	et	al.,	2000,	Piper	et	al.,	2013,	Schneider	
et	 al.,	 2010,	 Sha	 et	 al.,	 2004,	 Terajima	 et	 al.,	 1997,	 Xu	 et	 al.,	 2010).	 As	 observed	
previously,	 IL-1b	 stimulation	 did	 not	 induce	 the	 production	 of	 IFN	 or	 IFN-stimulated	
genes,	such	as	CCL5	and	CXCL11,	which	are	known	to	be	produced	in	response	to	RV	
infection	(Chen	et	al.,	2006,	Lin	et	al.,	1999,	Piper	et	al.,	2013).		
DUSP10	 knock	 down	 caused	 some	 changes	 in	 levels	 of	 cytokine	 release.	 Release	 of	
CXCL1	and	IL-1b	were	both	increased	in	DUSP10	knock	down	compared	to	control	siRNA	
treated	 cells,	with	 IL-1b	 levels	 almost	 doubling	 (Table	 4.2).	When	normalised	 to	 cell	
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PCR	 was	 performed	 for	 CXCL8	 and	 a	 GAPDH	 control.	 Data	 shown	 are	 fold	 change	
normalised	 to	GAPDH	control	 and	media	 control	 (A).	 Supernatant	was	 collected	and	
ELISA	 performed	 for	 CXCL8.	 Data	 shown	 are	 ng/ml	 normalised	 to	 cell	 counts	 (B).	
Significance	is	indicated	by	*	p	≤	0.05,	**	p	≤	0.01,	***	p	≤	0.001	between	control	and	














































































































































































































treated	 with	 DUSP10	 or	 control	 siRNA	 48	 h	 before	 simultaneous	 treatment	 with	
dexamethasone	and	poly(I:C),	and	the	level	of	CXCL8	mRNA	determined	by	qRT-PCR.	As	
seen	previously,	 in	 the	absence	of	dexamethasone,	poly(I:C)	 stimulation	upregulated	
CXCL8	mRNA	 and	 secreted	 protein	 levels	 (Figure	 4.16).	 In	 cells	 treated	with	 control	
siRNA	 dexamethasone	 treatment	 significantly	 reduced	 CXCL8	 mRNA	 production,	





















































































48	 h,	 then	 treated	 with	 dexamethasone	 (10	 nM)	 for	 4	 h	 prior	 to	 stimulation	 with	
poly(I:C)	 (25	µg/ml).	 qRT-PCR	was	 performed	 for	 CXCL8	 and	 a	 GAPDH	 control.	 Data	













































































known	 about	 its	 role	 in	 viral	 infection.	 Previous	work	 has	 suggested	 it	may	 have	 an	
important	role	in	viral	infection	of	the	airway,	as	siRNA	knock	down	in	the	epithelial	cell	
line	NCI-H292	increases	production	of	IL-6	and	CXCL8	in	response	to	poly(I:C)	stimulation	
(Golebski	et	al.,	2015).	 In	order	 to	 take	this	work	 further,	and	 investigate	the	role	of	
DUSP1	 in	 rhinoviral	 infection	of	epithelial	 cells,	 siRNA	knock	down	was	attempted	 in	
PBECs	and	the	epithelial	cell	lines	BEAS-2B	and	HeLa	Ohio.		










was	 productive	 and	 the	 siRNA	 complexes	 were	 entering	 the	 cells.	 The	 knock	 down	
efficiency	 was	 measured	 at	 the	 mRNA	 level,	 as	 well	 as	 the	 protein	 level,	 and	 no	
differences	were	 found.	As	 the	data	presented	 in	 chapter	 three	 shows	 low	 levels	 of	




































difference	 in	 cell	 types,	 the	 influenza	 paper	 examining	 murine	 BMDMs	 rather	 than	
human	epithelial	 cells.	DUSP10	may	have	specific	 roles	 in	different	cell	 types,	as	has	
been	 suggested	 for	DUSP1	 (Zhang	et	 al.,	 2015,	 Zhao	et	 al.,	 2017).	 It	 could	 also	be	 a	
species	 dependent	 phenotype,	 it	 would	 be	 interesting	 to	 determine	 the	 effect	 of	
DUSP10	knock	down	on	influenza	replication	in	human	PBECs.	






into	 the	 effect	 of	 DUSP10	 knock	 down	 on	 other	 IFNs	 may	 not	 be	 worthwhile.	 The	
significant	decrease	in	CCL5	production	in	DUSP10	knock	down	cells	seen	in	response	to	










glioblastomas,	 and	 an	 SNP	 in	 the	 DUSP10	 gene	 is	 associated	with	 colorectal	 cancer	
(Benavides-Serrato	et	al.,	2014,	Nomura	et	al.,	2012,	Zhang	et	al.,	2014).	However,	 it	









by	 the	 fact	 that	DUSP10	 is	 phosphorylated	 and	 stabilised	 by	mTORC2,	 an	 important	
regulator	of	cell	growth	(Benavides-Serrato	et	al.,	2014).	The	role	of	DUSP10	in	the	cell	
cycle	is	thought	to	be	through	regulation	of	the	MAPKs	(He	et	al.,	2014).	JNK	is	known	





The	MAPKs	 also	have	 roles	 in	 regulating	 tight	 junctions	between	 the	epithelial	 cells.	
Inhibition	of	either	ERK	or	JNK	has	been	shown	to	prevent	tight	junction	disassembly	in	
response	to	various	stimuli	 (Cohen	et	al.,	2010,	Petecchia	et	al.,	2012).	Disruption	of	
tight	 junctions	 is	 another	possible	mechanism	by	which	 loss	of	DUSP10	 leads	 to	 cell	
death;	 DUSP10	 knock	 down	 increasing	 MAPK	 activity	 leading	 to	 the	 loss	 of	 tight	
junctions.	 This	 has	 implications	 in	 rhinoviral	 infection,	 as	 infection	 also	 leads	 to	
disruption	of	tight	junctions	(Sajjan	et	al.,	2008,	Yeo	and	Jang,	2010).	Rhinoviral	infection	
causes	significant	damage	to	the	airway	epithelium	(Bossios	et	al.,	2005,	Wark	et	al.,	
2002).	 The	 role	 of	 DUSP10	 in	 regulation	 of	 the	 cell	 cycle	 or	 tight	 junctions	may	 be	
important	in	recovery	of	the	epithelium	after	infection.		
4.8.5 The	Role	of	DUSP10	in	Inflammatory	Cytokine	Release	
DUSP10	knock	down	did	not	affect	 inflammatory	cytokine	production	 in	 response	 to	
infection	 with	 either	 strain	 of	 rhinovirus,	 or	 poly(I:C)	 stimulation,	 suggesting	 that	
DUSP10	is	not	negatively	regulating	the	TLR3	signalling	pathway	in	PBECs.	It	is	possible	
that	 there	 could	 be	 redundancy	 between	 the	 DUSP	 proteins,	 with	 another	 protein	
compensating	 for	 the	 loss	 of	 DUSP10.	 Preliminary	 data	 suggests	 that	DUSP10	 knock	
down	 does	 not	 affect	 the	 mRNA	 expression	 of	 DUSP1	 (data	 not	 shown),	 but	 other	










In	 response	 to	 IL-1b	 stimulation,	 DUSP10	 knock	 down	 increased	 CXCL8	 mRNA	















of	 inflammatory	 cytokines,	 DUSP10	 is	 also	 regulating	 a	 pathway	 specific	 to	 IL-1b	
production.	IL-1b	is	produced	in	response	to	infection	or	stimulation	by	transcription	of	
pro-IL-1b,	 which	 is	 then	 cleaved	 into	 the	 active	 protein	 by	 the	 inflammasome.	 The	
inflammasome	consists	of	a	 sensor	protein,	 the	adaptor	protein	ASC,	and	caspase-1.	





NLRP3	 and	 NLRC5	 sense	 the	 changes	 in	 ion	 concentration,	 leading	 to	 activation	 of	
caspase-1,	and	 IL-1b	production.	As	 IL-1b	 is	differentially	expressed	 in	DUSP10	knock	
down	 cells,	 one	 possibility	 is	 that	 DUSP10	 is	 regulating	 inflammasome	 activation.	
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DUSP10	has	previously	been	linked	to	the	inflammasome	adaptor,	ASC,	as	THP-1	cells	
treated	 with	 ASC	 shRNA	 had	 increased	 DUSP10	 mRNA	 levels,	 suggesting	 that	 ASC	
supresses	DUSP10	production	(Taxman	et	al.,	2011).	The	interplay	between	DUSP10	and	
the	 inflammasome	 requires	 further	 investigation,	 for	 example	 measuring	 levels	 of	
caspase-1	activation	in	DUSP10	knock	down	cells.	The	levels	of	IL-1b	in	DUSP10	knock	




both	apoptosis	and	necrosis.	 It	 is	highly	 inflammatory,	resulting	from	cell	 lysis,	unlike	
apoptosis,	but	is	dependent	on	caspase-1	activation,	unlike	necrosis	(Fink	and	Cookson,	
2006).	 Infection	 of	 the	 neuroblastoma	 cell	 line	 SK-N-SH	 with	 the	 picornavirus,	
enterovirus-71	has	been	 found	 to	activate	 the	 inflammasome	and	 lead	 to	 cell	 death	
through	 pyroptosis	 (Yogarajah	 et	 al.,	 2017).	 If	 DUSP10	 does	 regulate	 inflammasome	
activation,	pyroptosis	could	be	another	mechanism	by	which	loss	of	DUSP10	leads	to	
cell	 death.	 One	 way	 in	 which	 to	 investigate	 whether	 DUSP10	 knock	 down	 induces	





Stimuli	 that	 induce	 production	 of	 IL-1b	 generally	 also	 induce	 IL-1ra,	 and	 IL-1b	
stimulation	 has	 been	 shown	 to	 induce	 release	 of	 IL-1ra	 (Gabay	 et	 al.,	 1997).	
Experimental	human	RV16	infection	showed	a	positive	correlation	between	levels	of	IL-





severity,	 viral	 titre	 and	 lymphocyte	 number	 (Spurrell	 et	 al.,	 2005).	 It	 has	 also	 been	





1b	 stimulation.	 This	 suggests	 that	DUSP10	positively	 regulates	 its	 release,	 and	 could	
have	 an	 important	 role	 in	 regulating	 the	 Th1/Th2	 axis	 in	 airway	 inflammation.	 The	




PBECs	 in	 response	 to	 RV16	 infection	 (Zaheer	 et	 al.,	 2009).	 This	 increase	 in	 CXCL10	
transcription	was	due	to	increased	activity	of	the	transcription	factor	IRF1.	IL-1	signalling	
has	 previously	 been	 found	 to	 induce	 IRF1	 activation	 and	 production	 of	 CXCL10	 in	









CXCL12	signalling	reduced	neutrophil	numbers	 in	the	murine	 lung	 in	response	to	LPS	
(Petty	 et	 al.,	 2007).	 In	 2011,	 Yamanda,	 et	 al.	 demonstrated	 that	 CXCL12	 expression	
increased	 lung	 neutrophil	 numbers	 by	 acting	 as	 a	 retention	 signal,	 rather	 than	 a	
chemoattractant,	and	protected	neutrophils	from	apoptosis	(Yamada	et	al.,	2011).	This	
implies	that	IL-1b	signalling	in	PBECs	reduces	the	production	of	a	neutrophil	retention	




involved	 in	 the	 TLR3	 signalling	 cascade.	 For	 example,	 IL-1b	 activates	 the	 MyD88	
pathway,	which	involves	phosphorylation	of	IRAK1	and/or	IRAK2,	which	are	not	involved	
in	 the	 TLR3-TRIF	 pathway.	DUSP10	 could	 be	 dephosphorylating	 these	 IRAK	proteins,	
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blocking	 this	 signalling	 pathway.	 However,	 activation	 of	 p38	 and	 JNK,	 which	 are	
downstream	of	the	IRAK	proteins,	in	response	to	IL-1b	was	unaffected	by	DUSP10	knock	
down.	 DUSP10	 could	 also	 be	 regulating	 these	 pathways	 in	 ways	 other	 than	
















Co-stimulating	PBECs	with	RV	and	 IL-1b	dramatically	potentiated	 the	 response	 to	RV	
alone.	 As	monocytes	 release	 IL-1b	 in	 response	 to	 infection	with	 RV	 (Ganesan	 et	 al.,	
2016);	 monocytes	 present	 in	 the	 infected	 airway	 would	 potentiate	 the	 response	 of	
PBECs	to	rhinoviral	 infection.	The	response	was	further	 increased	by	 loss	of	DUSP10.	
This	suggests	that	DUSP10	would	have	a	role	in	the	response	to	rhinoviral	infection	in	
the	airway;	RV	inducing	IL-1b	release	by	monocytes,	which	would	act	on	epithelial	cells	





Dexamethasone	 treatment	 is	 known	 to	 reduce	 the	 production	 of	 inflammatory	
cytokines	in	response	to	a	range	of	stimuli	(Abraham	et	al.,	2006,	Goleva	et	al.,	2013,	
Harada	et	al.,	2011,	Keranen	et	al.,	2017,	Newton	et	al.,	2010,	Papi	et	al.,	2013,	Rahman	




have	much	 of	 an	 effect	 on	 CXCL8	 production	 or	 release,	with	 or	without	 a	 4	 h	 pre-
treatment.	This	is	unexpected	as	dexamethasone	is	a	commonly	used	steroid	with	well	




having	 an	 effect.	 Many	 of	 the	 papers	 discussed	 above	 used	 1	 µM	 dexamethasone,	
including	 those	 studying	 PBECs,	 the	 effect	 of	 this	 on	 cell	 death	 was	 not	 presented	





alone	 and	 in	 combination	 with	 dexamethasone	 would	 indicate	 whether	 the	
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important	 role	 for	 IL-1b	 in	 cross-talk	 between	 macrophages	 and	 epithelial	 cells	 in	



















pathogens,	 and	 secreting	 inflammatory	 mediators.	 During	 an	 immune	 response,	





differentiate	 into	 recruited	 macrophages,	 including	 M1	 cells,	 which	 release	 pro-
inflammatory	mediators,	and	M2	cells	which	are	thought	to	have	an	anti-inflammatory	





this	 cooperative	 signalling	 between	 epithelial	 cells	 and	 monocytes	 can	 dramatically	
exacerbate	the	inflammatory	response	to	many	different	stimuli	(Chaudhuri	et	al.,	2010,	
Haller	et	al.,	2000,	Ishii	et	al.,	2005,	Morris	et	al.,	2006,	Stokes	et	al.,	2011,	Tsutsumi-Ishii	




cultures	 of	 primary	 monocytes	 and	 PBECs	 have	 also	 been	 found	 to	 have	 increased	
production	 of	 CCL2	 and	 CXCL10	 in	 response	 to	 RV16	 infection	 (Korpi-Steiner	 et	 al.,	
2010).	IL-1β	has	been	shown	to	be	particularly	important	in	this	signalling	network,	as	


















The	 results	 summarised	 in	 chapter	 four	 show	 that	 DUSP10	 negatively	 regulates	 the	
inflammatory	response	to	IL-1b	stimulation	of	epithelial	cells.	IL-1b	has	been	shown	to	





multi-cellular	 environment.	 The	 first	 aim	 was	 to	 determine	 whether	 rhinovirus	
replicated	in	monocytes	or	macrophages	and	characterise	their	response	to	the	virus.	














reaching	around	1,500	 copies	per	µg	by	48	h	when	 cells	were	 infected	 in	0%	 serum	














(B)	 infection	 in	 serum	 free	 media.	 RNA	 was	 collected	 at	 24	 and	 48	 h	 and	 qRT-PCR	




































































































































































































infection	 significantly	 increased	 IL-1b	 release	at	 24	h	post	 infection,	 this	was	 slightly	















































































































to	 determine	 whether	 factors	 released	 by	 monocytes,	 in	 response	 to	 rhinoviral	
infection,	 could	 activate	 epithelial	 cells.	 Monocytes	 were	 infected	 with	 RV	 and	
supernatant	collected	at	24	and	48	h.		Supernatant	was	filtered	to	remove	viral	particles	
before	 diluting	 1:2	 with	 PBEC	 recovery	 media,	 hereafter	 called	 conditioned	 media.	
PBECs	were	pre-treated	with	DUSP10	or	control	siRNA	before	addition	of	conditioned	
media	 for	24	h,	methodology	 is	 shown	 in	 figure	5.6	A.	CXCL8	mRNA	production	and	
protein	secretion	was	measured.		
Transfer	of	supernatant	from	uninfected	monocytes	to	PBECs	caused	some	CXCL8	mRNA	










Figure	 5.6	 Supernatant	 from	 monocytes	 infected	 with	 RV1B	 can	 induce	 CXCL8	
production	in	PBECs.		
Monocytes	 were	 infected	 with	 RV1B	 (MOI	 4)	 for	 0,	 24	 or	 48	 h,	 in	 0%	 serum,	 and	



















































































Figure	 5.7	 Supernatant	 from	 monocytes	 infected	 with	 RV16	 can	 induce	 CXCL8	
production	in	PBECs.	
Monocytes	 were	 infected	 with	 RV16	 (MOI	 4)	 for	 0,	 24	 or	 48	 h,	 in	 0%	 serum	 and	





































































































































Rhinovirus	has	been	 shown	 to	 induce	 secretion	of	 CXCL8	 and	 IL-1b	 in	monocytes	or	
macrophages	 previously.	 Infection	 of	 PBMCs	 with	 RV9	 induced	 CXCL8	 release,	 and	
infection	of	MDMs	with	RV16	induced	IL-1b	release	(Ganesan	et	al.,	2016,	Johnston	et	
al.,	1997).	In	this	study,	monocytes	released	both	cytokines	at	baseline,	and	expression	













of	PBECs	 to	 rhinoviral	 infection,	 the	cross-talk	between	monocytes	and	PBECs	 in	 the	
response	to	RV	was	then	investigated.	Supernatant	transfer	from	monocytes	to	PBECs	
induced	small	amounts	of	CXCL8	production	and	release.	This	showed	that	molecules	
released	by	 the	monocytes	 are	 able	 to	 stimulate	 cytokine	production	by	PBECs,	 and	
CXCL8	 mRNA	 levels	 were	 consistently	 higher	 in	 cells	 treated	 with	 DUSP10	 siRNA.	
However,	this	CXCL8	production	was	not	upregulated	by	rhinoviral	infection,	likely	due	
to	 the	 high	 baseline	 levels	 of	 cytokine	 production	 in	 monocytes.	 This	 experiment	
demonstrates	that	the	presence	of	monocytes	could	potentiate	the	response	of	PBECs	




monocytes,	 the	 role	 of	 DUSP10	 in	 the	 interplay	 between	 the	 two	 cells	 types	 was	







This	 is	 the	 first	 study	 to	 investigate	 DUSP	 regulation	 of	 epithelial	 inflammatory	
responses	 to	 respiratory	 viral	 infection.	 Respiratory	 inflammation	 is	 a	 damaging	











that	 the	p38	pathway	 is	necessary	 for	 replication	of	RV,	although	this	has	previously	
been	shown	 for	other	viruses	 (Marchant	et	al.,	2010).	 In	opposition	 to	 this,	 JNK	was	


















(Morris	 et	 al.,	 2005,	 Stokes	 et	 al.,	 2011).	 This	 suggests	 that	 DUSP10	would	 have	 an	
important	anti-inflammatory	role	in	rhinoviral	infection	of	the	airway.	This	is	reinforced	








inflammation	 in	 response	 to	 influenza	 virus	 (Kim	 et	 al.,	 2015,	 Thomas	 et	 al.,	 2009).	






regulated	within	 the	 infected	airway.	This	 is	 summarised	 in	 figure	6.1.	 In	 this	model,	
rhinovirus	infects	epithelial	cells	lining	the	airway	where	it	activates	pattern	recognition	
receptors	and	innate	immune	signalling	pathways,	including	the	MAPK	pathways.	This	
leads	 to	 the	 production	 of	 inflammatory	 cytokines	 which	 are	 secreted,	 recruiting	
immune	 cells	 such	 as	 monocytes	 to	 the	 site	 of	 infection.	 Rhinovirus	 infects	 and	
replicates	within	 these	monocytes,	 causing	 them	 to	 release	 inflammatory	 cytokines,	
including	 IL-1b.	 IL-1b	 binds	 to	 the	 receptor	 IL-1Ra	 on	 the	 surface	 of	 epithelial	 cells	
activating	 innate	 immune	 signalling	 pathways	 and	 the	 production	 of	 cytokines,	










chemotaxis.	 Rhinovirus	 infects	 and	 replicates	within	monocytes.	 Infected	monocytes	












any	 patterns	 caused	 by	 donor	 characteristics.	 This	 donor	 variability	makes	 the	 data	
difficult	to	interpret	and	changes	may	be	missed	due	to	large	error	bars.	The	application	
of	 statistical	 tests	 to	 small	 numbers	 of	 replicates	 is	 also	 difficult	 and	 statistical	
significance	is	less	likely	to	be	found.	Therefore,	the	data	presented	here	would	be	made	
much	 more	 robust	 by	 the	 inclusion	 of	 a	 larger	 number	 of	 donors.	 However,	 the	
interesting	findings	within	this	study,	for	example	the	increase	in	CXCL8	production	in	
response	to	IL-1b	when	DUSP10	is	knocked	down,	are	clear.		
Another	 limitation	 is	 the	 use	 of	 small	 molecule	 inhibitors	 against	 the	 MAPKs.	 As	










If	 DUSPs	 are	 to	 be	 used	 as	 future	 therapeutic	 targets	 for	 rhinoviral	 infection,	 it	 is	











of	 DUSP1	 than	 poly(I:C),	 suggesting	 that	 this	 is	 independent	 of	 TLR3.	 The	 pathway	
leading	to	this	phosphorylation	event	and	the	kinase	responsible	are	unknown.	An	early	














the	 inflammatory	 response	 to	 rhinovirus.	 This	mechanism	 is	 presented	 in	 figure	 6.1,	
however,	the	point	in	the	IL-1b	signalling	pathway	at	which	DUSP10	is	acting	remains	
unknown.	Potential	sites	at	which	DUSP10	may	act	are	presented	in	figure	4.18.	Data	
presented	 in	 this	 thesis	 suggests	 that	 DUSP10	 is	 not	 dephosphorylating	 the	 MAPK	
proteins	p38	or	JNK,	as	DUSP10	knock	down	did	not	increase	p38	or	JNK	activation	levels,	
however	 it	 is	 possible	 that	 the	 activation	 could	 be	 prolonged.	While	 this	 should	 be	
further	investigated,	it	would	also	be	interesting	to	investigate	whether	DUSP10	is	acting	
at	a	different,	novel,	point.	 If	 funding	were	available,	 it	would	be	exciting	to	utilise	a	
commercially	available	antibody	screen,	specific	to	phosphorylated	proteins.	This	would	
enable	the	identification	of	any	unknown	targets	of	DUSP10.	Expression	of	CXCL10	in	
response	 to	 IL-1b	 was	 decreased	 when	 DUSP10	 was	 knocked	 down.	 CXCL10	 is	
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transcriptionally	 induced	 by	 IRF1.	 Although	 this	 finding	 should	 be	 confirmed	using	 a	
more	 quantitative	 technique,	 such	 as	 ELISA,	 and	 samples	 from	 multiple	 donors,	 it	




causes	 significant	 cell	 death.	 Further	 investigation	 is	 required	 to	 determine	 the	
mechanism	of	cell	death:	pyroptosis,	apoptosis	or	necrosis.		
IL-1b	is	known	to	have	an	important	role	in	the	cross-talk	between	epithelial	cells	and	
monocytes	 in	 rhinoviral	 infection	 (Section	 5.1).	 This	 suggests	 that	 DUSP10	 has	 an	





but	 cell-cell	 contacts	 (Lee	 and	 Rannels,	 1996,	 Tao	 and	 Kobzik,	 2002).	 However,	
monocytes	released	high	levels	of	cytokines	at	baseline,	likely	due	to	the	stress	caused	
by	a	 lack	of	serum.	 In	order	 to	move	forward	 into	co-culture	models,	optimisation	 is	






pathways	 before	 they	 can	 be	 manipulated	 for	 therapeutic	 use.	 This	 includes	
identification	of	the	proteins	targeted	by	DUSP10,	further	characterisation	of	regulation	





Exacerbations	 of	 asthma	 and	 COPD	 caused	 by	 rhinoviral	 infections	 represent	 a	
significant	cause	of	morbidity	and	mortality.	It	is	therefore	important	to	develop	new	
therapeutics	aimed	at	limiting	the	excessive	inflammatory	response	to	RV.	In	order	to	
do	 this,	 the	 pathways	 leading	 to	 this	 response	 and	 their	 regulation	 need	 to	 be	 fully	
characterised.	 This	 study	 has	 identified	 two	 pathways,	 p38	 and	 JNK,	 as	 important	
inducers	of	 inflammation	 in	response	to	RV,	and	characterised	the	expression	of	two	
potential	 regulators,	 DUSPs	 1	 and	 10.	 Both	 proteins	 were	 expressed	 in	 PBECs	 and	
regulated	by	RV	infection.	A	novel	role	for	DUSP10	was	characterised	in	limiting	cytokine	
production	in	response	to	IL-1b	alone,	and	in	combination	with	RV.	Therefore,	DUSP10	
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